Microarray analysis of bone marrow-derived macrophage cells treated with Kdo2-lipid A (KLA) and ATP

Search by fold change ratio | Search by KEGG pathway | Search by LIPID MAPS lipid pathway

Kdo2-Lipid A / ATP gene array data - treatment:control ratios

KEGG pathway: Viral carcinogenesis (mmu05203)

Legend:graph_icon: View data/graphs for replicates
Gene symbol    Time course plot Accession Description Treatment 15min 30min 1hr 2hr 4hr 8hr 20hr
14927508
3
KLA  ATP  ATP+KLA
 149275083 Unknown KLA .74 .68 .68 .77 .71 .85 .69
ATP .85 .69 1.26 .89 .89 1.26 .64
KLA/ATP .64 .63 1.07 .96 1.39 1.07 .82
1700014N
06Rik
KLA  ATP  ATP+KLA
 AK005982 adult male testis cDNA, RIKEN full-length enriched library, clone:1700014N06 product:HISTONE H2B, full insert sequence [AK005982] KLA .97 .96 1.05 1.06 1.01 1.00 1.00
ATP 1.01 1.03 1.03 .99 1.00 1.00 1.00
KLA/ATP .91 1.06 1.06 1.01 1.04 .96 .93
1700024P
04Rik
KLA  ATP  ATP+KLA
 BU938589 gb|AGENCOURT_10517723 NIH_MGC_169 Mus musculus cDNA clone IMAGE:6706749 5, mRNA sequence [BU938589] KLA .92 .86 .99 1.02 .96 .97 .99
ATP .95 .87 1.05 .99 .94 .97 .92
KLA/ATP .98 1.00 1.02 1.01 1.04 .88 .94
AK031249
KLA  ATP  ATP+KLA
 AK031249 13 days embryo forelimb cDNA, RIKEN full-length enriched library, clone:5930437C20 product:hypothetical protein, full insert sequence [AK031249] KLA .95 1.00 .98 .99 .96 1.01 1.07
ATP .92 1.02 1.10 1.15 1.22 1.03 1.01
KLA/ATP .96 .97 1.10 1.15 1.05 1.11 1.02
AK045358
KLA  ATP  ATP+KLA
 AK045358 adult male corpora quadrigemina cDNA, RIKEN full-length enriched library, clone:B230105H23 product:voltage-dependent anion channel 3, full insert sequence [AK045358] KLA .96 .98 .96 .96 1.02 1.03 1.01
ATP .97 .95 1.01 .99 1.08 1.01 .97
KLA/ATP .99 .99 .98 1.01 .99 1.06 .99
Actn1
KLA  ATP  ATP+KLA
 NM_134156 actinin, alpha 1 (Actn1), mRNA [NM_134156] KLA 1.33 1.42 1.46 1.16 1.18 .69 .54
ATP 1.06 1.13 .67 1.15 .95 .99 1.46
KLA/ATP 1.66 1.64 .81 1.55 .82 .78 .76
Actn2
KLA  ATP  ATP+KLA
 NM_033268 actinin alpha 2 (Actn2), mRNA [NM_033268] KLA 1.03 .94 1.02 1.05 1.02 1.06 1.11
ATP 1.04 .98 1.07 .99 1.10 1.03 1.02
KLA/ATP 1.06 1.03 .99 1.08 1.01 1.05 .98
Actn3
KLA  ATP  ATP+KLA
 NM_013456 actinin alpha 3 (Actn3), mRNA [NM_013456] KLA .97 .98 .98 .94 1.03 .96 1.07
ATP .95 .95 1.02 .98 .94 .95 1.01
KLA/ATP 1.05 1.03 .94 1.03 1.03 1.00 .95
Actn4
KLA  ATP  ATP+KLA
 NM_021895 actinin alpha 4 (Actn4), mRNA [NM_021895] KLA .78 .77 .75 .74 .58 .51 .65
ATP 1.03 1.03 1.21 1.14 1.50 1.30 1.09
KLA/ATP .78 .85 .96 .84 1.09 1.12 .97
Atf2
KLA  ATP  ATP+KLA
 AK047405 10 days neonate cerebellum cDNA, RIKEN full-length enriched library, clone:B930056P03 product:activating transcription factor 2, full insert sequence. [AK047405] KLA 1.01 1.00 1.02 1.04 1.03 1.03 1.00
ATP .99 1.00 .95 1.01 1.04 .98 1.03
KLA/ATP 1.07 1.00 .98 .99 1.00 1.03 .93
Atf2
KLA  ATP  ATP+KLA
 NM_001025093 activating transcription factor 2 (Atf2), transcript variant 1, mRNA [NM_001025093] KLA 1.35 1.30 1.32 1.31 1.37 1.09 1.20
ATP 1.15 1.17 .99 1.11 1.22 1.39 1.28
KLA/ATP 1.38 1.42 1.21 1.28 1.17 1.33 1.69
Atf4
KLA  ATP  ATP+KLA
 NM_009716 activating transcription factor 4 (Atf4), mRNA [NM_009716] KLA .91 1.06 1.13 1.31 1.92 2.59 3.01
ATP 1.05 1.14 1.34 2.88 4.84 2.36 2.56
KLA/ATP 1.14 1.08 1.17 2.40 3.72 3.54 3.62
Atp6v0d1
KLA  ATP  ATP+KLA
 NM_013477 ATPase, H+ transporting, lysosomal V0 subunit D1 (Atp6v0d1), mRNA [NM_013477] KLA .84 .85 .94 .79 1.10 1.24 1.27
ATP 1.18 1.48 .94 1.40 1.12 .75 1.85
KLA/ATP 1.05 1.06 .59 1.06 .83 .85 1.96
Atp6v0d2
KLA  ATP  ATP+KLA
 NM_175406 ATPase, H+ transporting, lysosomal V0 subunit D2 (Atp6v0d2), mRNA [NM_175406] KLA .77 .72 .64 .54 .43 .27 .18
ATP 1.19 1.35 1.06 1.47 1.46 .79 .96
KLA/ATP .78 .95 .63 1.12 1.21 1.01 .50
BB217526
KLA  ATP  ATP+KLA
 AK083592 9 days embryo whole body cDNA, RIKEN full-length enriched library, clone:D030051F04 product:unclassifiable, full insert sequence [AK083592] KLA 1.53 1.19 1.21 1.15 1.61 1.14 .87
ATP 1.33 1.11 1.15 1.11 2.06 1.48 1.13
KLA/ATP 1.36 1.18 1.61 1.37 1.77 1.10 1.13
BB483579
KLA  ATP  ATP+KLA
 BB483579 gb|BB483579 RIKEN full-length enriched, 13 days embryo lung Mus musculus cDNA clone D430021C16 3. [BB483579] KLA .99 1.01 .84 .82 .90 .92 .99
ATP .95 .84 .71 .82 .86 .89 .96
KLA/ATP .91 .84 .78 .79 .84 .96 .94
Bad
KLA  ATP  ATP+KLA
 AK029400 0 day neonate head cDNA, RIKEN full-length enriched library, clone:4833429M11 product:Bcl-associated death promoter, full insert sequence. [AK029400] KLA 1.15 1.22 1.26 1.31 1.40 1.67 1.59
ATP .95 1.06 1.12 1.06 .78 .89 1.27
KLA/ATP 1.25 1.39 1.33 1.29 1.11 .91 1.38
Bak1
KLA  ATP  ATP+KLA
 NM_007523 BCL2-antagonist/killer 1 (Bak1), mRNA [NM_007523] KLA 1.31 1.34 1.44 1.48 1.81 1.82 1.83
ATP 1.11 1.20 1.01 1.21 1.08 1.18 1.66
KLA/ATP 1.42 1.40 1.24 1.47 1.24 1.56 2.66
Bax
KLA  ATP  ATP+KLA
 NM_007527 Bcl2-associated X protein (Bax), mRNA [NM_007527] KLA 1.08 1.14 1.10 1.14 1.17 1.06 .92
ATP 1.06 1.05 1.02 1.25 1.26 .90 .86
KLA/ATP 1.11 1.19 1.30 1.34 1.34 .87 .71
C3
KLA  ATP  ATP+KLA
 NM_009778 complement component 3 (C3), mRNA [NM_009778] KLA 28.58 25.57 24.39 27.34 23.38 23.21 18.10
ATP 1.04 .93 1.21 1.90 2.80 5.74 12.19
KLA/ATP 27.04 26.10 33.29 23.09 25.65 23.77 40.22
Casp3
KLA  ATP  ATP+KLA
 NM_009810 caspase 3 (Casp3), mRNA [NM_009810] KLA 1.66 1.94 2.47 2.61 3.01 2.96 1.44
ATP .90 .99 1.17 1.30 1.01 1.17 .86
KLA/ATP 1.55 1.87 2.40 2.35 2.27 2.84 2.52
Casp3
KLA  ATP  ATP+KLA
 U49929 ICE-like cysteine protease (Lice) mRNA, complete cds. [U49929] KLA 1.71 1.87 2.69 3.11 3.64 3.42 1.52
ATP 1.04 1.07 1.16 1.34 .98 1.27 .86
KLA/ATP 1.80 1.96 2.46 2.91 2.50 3.24 3.10
Casp8
KLA  ATP  ATP+KLA
 NM_009812 caspase 8 (Casp8), transcript variant 1, mRNA [NM_009812] KLA 2.41 2.53 3.20 3.26 2.75 2.78 1.57
ATP .91 .96 .66 .67 .54 1.53 1.52
KLA/ATP 2.47 2.52 2.08 2.41 1.41 2.50 2.77
Ccna1
KLA  ATP  ATP+KLA
 NM_007628 cyclin A1 (Ccna1), mRNA [NM_007628] KLA .97 .96 1.03 1.01 .97 .96 1.02
ATP .98 .99 1.00 1.01 .98 .95 .98
KLA/ATP 1.05 .96 1.01 1.04 .97 .92 1.01
Ccna2
KLA  ATP  ATP+KLA
 NM_009828 cyclin A2 (Ccna2), mRNA [NM_009828] KLA .28 .21 .19 .14 .09 .07 .06
ATP 1.17 1.11 1.03 1.01 .59 .20 .05
KLA/ATP .29 .22 .23 .21 .13 .08 .06
Ccnd1
KLA  ATP  ATP+KLA
 S78355 gb|Cyl-1=cyclin D1 [mice, BALB/c, brain, mRNA, 3737 nt]. [S78355] KLA .24 .23 .23 .24 .29 .47 .17
ATP 1.02 1.02 .88 .80 .52 .10 .21
KLA/ATP .27 .23 .22 .24 .27 .25 .14
Ccnd2
KLA  ATP  ATP+KLA
 NM_009829 cyclin D2 (Ccnd2), mRNA [NM_009829] KLA 12.92 13.66 11.94 12.37 11.11 5.44 1.53
ATP .98 .75 .50 .57 1.24 2.83 .40
KLA/ATP 11.19 11.62 10.34 7.96 7.92 7.10 2.57
Ccnd3
KLA  ATP  ATP+KLA
 NM_007632 cyclin D3 (Ccnd3), transcript variant 1, mRNA [NM_007632] KLA .60 .65 .86 1.02 1.91 2.26 1.45
ATP 1.05 1.14 .89 1.20 .74 .76 .99
KLA/ATP .70 .67 .54 .83 .61 1.19 1.45
Ccne1
KLA  ATP  ATP+KLA
 NM_007633 cyclin E1 (Ccne1), mRNA [NM_007633] KLA 1.13 1.14 1.13 .78 .51 .69 .55
ATP .92 .94 1.09 .93 .75 .71 .47
KLA/ATP 1.13 1.17 1.45 1.24 1.33 1.50 .85
Ccne2
KLA  ATP  ATP+KLA
 NM_001037134 cyclin E2 (Ccne2), transcript variant 1, mRNA [NM_001037134] KLA .34 .35 .42 .36 .35 .36 .26
ATP 1.02 1.11 1.01 .82 .58 .38 .23
KLA/ATP .36 .34 .44 .43 .41 .40 .25
Ccr3
KLA  ATP  ATP+KLA
 NM_009914 chemokine (C-C motif) receptor 3 (Ccr3), mRNA [NM_009914] KLA 1.22 1.12 1.02 1.02 1.06 1.32 1.45
ATP 1.09 1.22 1.38 1.47 1.17 1.41 4.85
KLA/ATP 1.23 1.29 1.16 1.14 .80 .71 3.44
Ccr4
KLA  ATP  ATP+KLA
 NM_009916 chemokine (C-C motif) receptor 4 (Ccr4), mRNA [NM_009916] KLA .97 1.00 .99 1.00 1.06 1.06 1.05
ATP 1.03 .97 .98 1.05 .96 .99 1.07
KLA/ATP 1.01 1.01 .99 1.05 .98 .99 1.01
Ccr5
KLA  ATP  ATP+KLA
 NM_009917 chemokine (C-C motif) receptor 5 (Ccr5), mRNA [NM_009917] KLA .92 .90 1.34 1.58 1.78 1.69 2.02
ATP 1.09 1.04 1.14 1.01 .71 .62 1.40
KLA/ATP .96 .98 1.28 1.29 1.04 .67 1.57
Ccr8
KLA  ATP  ATP+KLA
 NM_007720 chemokine (C-C motif) receptor 8 (Ccr8), mRNA [NM_007720] KLA 1.05 .96 .95 1.04 1.02 1.05 1.02
ATP .98 1.02 1.06 1.00 .98 1.03 1.05
KLA/ATP .92 .93 1.02 .99 1.00 .97 1.11
Cdc20
KLA  ATP  ATP+KLA
 NM_023223 cell division cycle 20 homolog (S. cerevisiae) (Cdc20), mRNA [NM_023223] KLA .18 .15 .14 .12 .10 .09 .06
ATP .91 .88 1.33 1.11 .72 .46 .07
KLA/ATP .16 .15 .20 .18 .19 .17 .07
Cdc2a
KLA  ATP  ATP+KLA
 NM_007659 cell division cycle 2 homolog A (S. pombe) (Cdc2a), mRNA [NM_007659] KLA .72 .68 .65 .58 .58 .59 .48
ATP 1.01 1.05 1.21 1.06 .83 .77 .51
KLA/ATP .68 .63 .79 .70 .59 .59 .51
Cdc42
KLA  ATP  ATP+KLA
 NM_009861 cell division cycle 42 homolog (S. cerevisiae) (Cdc42), mRNA [NM_009861] KLA 1.04 1.01 1.02 1.04 1.12 1.21 1.12
ATP 1.07 1.10 1.04 1.06 1.02 .95 1.14
KLA/ATP .94 1.04 1.01 .97 .95 1.02 1.25
Cdk2
KLA  ATP  ATP+KLA
 NM_016756 cyclin-dependent kinase 2 (Cdk2), transcript variant 2, mRNA [NM_016756] KLA .68 .67 .62 .63 .60 .74 .73
ATP 1.02 1.14 .91 .92 .68 .71 .65
KLA/ATP .67 .64 .64 .64 .61 .74 .62
Cdk4
KLA  ATP  ATP+KLA
 NM_009870 cyclin-dependent kinase 4 (Cdk4), mRNA [NM_009870] KLA .66 .72 .65 .55 .46 .50 .71
ATP 1.03 1.02 .53 .65 .66 .63 .75
KLA/ATP .78 .61 .31 .42 .44 .62 .43
Cdk6
KLA  ATP  ATP+KLA
 AK030810 adult male thymus cDNA, RIKEN full-length enriched library, clone:5830411I20 product:unclassifiable, full insert sequence [AK030810] KLA 1.05 .96 .67 .51 .48 .49 .45
ATP 1.02 .91 .78 .49 .50 .47 .44
KLA/ATP 1.01 .89 .65 .40 .36 .26 .49
Cdk6
KLA  ATP  ATP+KLA
 NM_009873 cyclin-dependent kinase 6 (Cdk6), mRNA [NM_009873] KLA 2.63 2.36 2.14 1.80 1.55 1.32 1.03
ATP 1.11 1.21 1.06 1.23 .94 1.30 2.08
KLA/ATP 2.58 2.69 2.24 2.25 1.38 .85 3.00
Cdkn1a
KLA  ATP  ATP+KLA
 NM_007669 cyclin-dependent kinase inhibitor 1A (P21) (Cdkn1a), transcript variant 1, mRNA [NM_007669] KLA 4.72 4.90 4.96 3.73 2.11 1.14 1.02
ATP 1.14 1.52 .95 1.69 1.47 2.21 .50
KLA/ATP 5.99 7.08 3.86 6.37 3.00 2.55 2.05
Cdkn1b
KLA  ATP  ATP+KLA
 NM_009875 cyclin-dependent kinase inhibitor 1B (Cdkn1b), mRNA [NM_009875] KLA .81 .84 .84 .91 .93 .88 .97
ATP .99 1.09 .97 1.06 1.48 .94 .91
KLA/ATP .83 .91 1.04 1.36 1.48 1.06 1.09
Cdkn2a
KLA  ATP  ATP+KLA
 NM_009877 cyclin-dependent kinase inhibitor 2A (Cdkn2a), transcript variant 1, mRNA [NM_009877] KLA .95 .95 .86 .96 .91 .90 .75
ATP 1.00 .99 .95 .95 .97 .89 .77
KLA/ATP .95 .96 .92 .94 .90 .85 .76
Cdkn2b
KLA  ATP  ATP+KLA
 NM_007670 cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4) (Cdkn2b), mRNA [NM_007670] KLA .70 .75 .94 1.44 1.66 .55 .81
ATP 1.02 .89 1.00 .86 1.33 3.87 .57
KLA/ATP .71 .77 .91 .94 .74 1.64 1.17
Chd4
KLA  ATP  ATP+KLA
 NM_145979 chromodomain helicase DNA binding protein 4 (Chd4), mRNA [NM_145979] KLA 1.26 1.23 1.18 1.08 1.21 1.11 .95
ATP 1.11 1.14 1.10 2.36 1.64 1.25 1.04
KLA/ATP 1.34 1.46 1.19 1.99 1.57 1.19 1.24
Chek1
KLA  ATP  ATP+KLA
 NM_007691 checkpoint kinase 1 homolog (S. pombe) (Chek1), mRNA [NM_007691] KLA .36 .35 .37 .36 .34 .44 .31
ATP 1.12 1.14 1.17 1.08 .64 .43 .32
KLA/ATP .37 .36 .48 .46 .49 .36 .25
Creb1
KLA  ATP  ATP+KLA
 NM_009952 cAMP responsive element binding protein 1 (Creb1), transcript variant B, mRNA [NM_009952] KLA 1.42 1.33 1.16 .99 .83 .97 .92
ATP .92 .91 1.18 1.38 1.51 1.02 .75
KLA/ATP 1.34 1.31 1.49 1.37 1.71 1.05 .93
Creb3
KLA  ATP  ATP+KLA
 NM_013497 cAMP responsive element binding protein 3 (Creb3), mRNA [NM_013497] KLA 1.21 1.21 1.23 1.53 1.77 1.77 1.31
ATP 1.02 1.03 .99 1.05 .82 .83 1.48
KLA/ATP 1.15 1.18 1.20 1.26 1.13 1.15 1.86
Creb3l1
KLA  ATP  ATP+KLA
 NM_011957 cAMP responsive element binding protein 3-like 1 (Creb3l1), mRNA [NM_011957] KLA 1.18 1.17 1.53 1.28 1.22 1.11 1.23
ATP 1.01 1.09 .98 1.17 1.22 1.01 1.15
KLA/ATP 1.22 1.29 1.08 1.34 1.14 1.36 1.12
Creb3l2
KLA  ATP  ATP+KLA
 AK082964 12 days embryo spinal cord cDNA, RIKEN full-length enriched library, clone:C530025K05 product:unclassifiable, full insert sequence [AK082964] KLA .44 .38 .37 .40 .45 .42 .47
ATP .90 .78 1.22 .79 .54 .46 .44
KLA/ATP .41 .41 .49 .43 .50 .51 .23
Creb3l2
KLA  ATP  ATP+KLA
 NM_178661 cAMP responsive element binding protein 3-like 2 (Creb3l2), mRNA [NM_178661] KLA .98 .87 .76 .98 1.03 .87 1.12
ATP 1.20 1.18 1.50 1.35 .86 1.32 1.50
KLA/ATP .98 1.04 1.15 1.05 .79 1.27 1.25
Creb3l3
KLA  ATP  ATP+KLA
 NM_145365 cAMP responsive element binding protein 3-like 3 (Creb3l3), mRNA [NM_145365] KLA .66 .75 .65 .85 1.04 1.44 1.73
ATP 1.02 .98 .97 1.09 .85 .69 1.11
KLA/ATP .70 .66 .71 .83 .80 .85 1.05
Creb3l4
KLA  ATP  ATP+KLA
 NM_030080 cAMP responsive element binding protein 3-like 4 (Creb3l4), mRNA [NM_030080] KLA 1.55 1.42 1.51 1.73 1.76 2.54 1.38
ATP 1.07 .81 .89 1.08 .94 1.08 1.08
KLA/ATP 1.44 1.38 1.44 1.25 1.30 1.26 2.24
Creb5
KLA  ATP  ATP+KLA
 AK051306 12 days embryo spinal ganglion cDNA, RIKEN full-length enriched library, clone:D130032G03 product:unclassifiable, full insert sequence. [AK051306] KLA 2.18 2.13 2.42 1.97 1.57 1.94 1.98
ATP 1.11 1.09 1.47 1.74 1.36 1.44 1.62
KLA/ATP 2.55 2.77 3.02 3.15 2.51 2.52 2.61
Creb5
KLA  ATP  ATP+KLA
 NM_172728 cAMP responsive element binding protein 5 (Creb5), mRNA [NM_172728] KLA 3.70 3.60 2.84 2.39 1.92 2.81 1.84
ATP .92 .89 1.19 1.93 1.51 1.55 1.44
KLA/ATP 3.16 3.51 4.33 5.35 5.78 3.23 3.03
Crebbp
KLA  ATP  ATP+KLA
 AK048818 0 day neonate cerebellum cDNA, RIKEN full-length enriched library, clone:C230072N21 product:hypothetical protein, full insert sequence [AK048818] KLA 1.44 1.19 1.26 1.25 1.25 1.36 1.24
ATP .98 .90 1.04 1.11 1.95 2.72 1.51
KLA/ATP 1.17 1.27 1.45 1.28 1.98 2.80 2.52
Crebbp
KLA  ATP  ATP+KLA
 NM_001025432 CREB binding protein (Crebbp), mRNA [NM_001025432] KLA .97 1.01 .98 1.06 1.05 .99 1.07
ATP 1.07 1.05 .96 1.01 1.15 1.14 1.00
KLA/ATP 1.01 .97 .97 1.00 1.03 1.23 1.13
Crebbp
KLA  ATP  ATP+KLA
 S66385 gb|CREB-binding protein [mice, brain, mRNA Partial, 7326 nt]. [S66385] KLA 1.00 .98 1.08 .98 1.04 1.07 1.08
ATP .99 .98 .99 1.09 1.13 1.08 1.05
KLA/ATP 1.06 1.00 1.05 1.03 1.02 1.14 1.11
Crebl1
KLA  ATP  ATP+KLA
 NM_017406 cAMP responsive element binding protein-like 1 (Crebl1), mRNA [NM_017406] KLA 1.22 1.30 1.32 1.34 1.51 1.52 1.75
ATP 1.13 1.32 1.16 1.66 1.06 .93 1.54
KLA/ATP 1.37 1.25 1.21 1.74 1.04 1.01 2.07
D1Pas1
KLA  ATP  ATP+KLA
 NM_033077 DNA segment, Chr 1, Pasteur Institute 1 (D1Pas1), mRNA [NM_033077] KLA 1.05 1.01 1.03 .94 .90 .78 .79
ATP 1.05 1.14 1.01 1.26 1.15 .97 .79
KLA/ATP 1.04 1.09 1.06 1.18 .97 .86 .80
Ddb1
KLA  ATP  ATP+KLA
 NM_015735 damage specific DNA binding protein 1 (Ddb1), mRNA [NM_015735] KLA 1.01 1.01 1.01 .83 .75 .62 .68
ATP 1.05 1.21 .88 1.04 1.01 .76 .61
KLA/ATP 1.17 1.09 .77 .91 .58 .54 .45
Ddx3x
KLA  ATP  ATP+KLA
 NM_010028 DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide 3, X-linked (Ddx3x), mRNA [NM_010028] KLA 1.00 1.03 1.01 .90 .76 .56 .66
ATP 1.18 1.17 1.11 1.24 1.16 .93 .62
KLA/ATP 1.04 1.20 1.21 1.10 .89 .73 .59
Ddx3x
KLA  ATP  ATP+KLA
 U42386 fibroblast growth factor inducible gene 14 (FIN14) mRNA, complete cds. [U42386] KLA .72 .68 .66 .63 .49 .40 .43
ATP .99 .91 1.27 .93 1.14 1.01 .32
KLA/ATP .72 .81 .92 .75 1.00 .68 .20
Ddx3y
KLA  ATP  ATP+KLA
 AK020213 15 days embryo male testis cDNA, RIKEN full-length enriched library, clone:8030469F12 product:unclassifiable, full insert sequence. [AK020213] KLA 1.08 .99 1.03 1.07 .97 1.14 1.02
ATP .99 1.01 1.33 .98 .75 .98 .79
KLA/ATP .98 1.02 1.15 .84 .76 .89 .91
Ddx3y
KLA  ATP  ATP+KLA
 NM_012008 DEAD (Asp-Glu-Ala-Asp) box polypeptide 3, Y-linked (Ddx3y), mRNA [NM_012008] KLA 1.10 1.07 1.03 .97 1.20 1.07 .88
ATP 1.21 1.25 1.24 .87 .85 .94 .77
KLA/ATP 1.05 1.09 1.08 .76 .60 .71 .85
Dlg1
KLA  ATP  ATP+KLA
 AK031364 13 days embryo male testis cDNA, RIKEN full-length enriched library, clone:6030413K05 product:discs, large homolog 1 (Drosophila), full insert sequence. [AK031364] KLA .92 .85 .88 .82 .95 .91 .98
ATP 1.11 1.01 .90 .87 1.03 .93 .92
KLA/ATP .94 .93 .80 .81 1.01 .90 .87
Dlg1
KLA  ATP  ATP+KLA
 NM_007862 discs, large homolog 1 (Drosophila) (Dlg1), mRNA [NM_007862] KLA 1.17 1.11 1.13 1.05 .89 .91 1.05
ATP .98 .97 1.13 1.12 .90 .96 .91
KLA/ATP 1.24 1.11 1.14 1.02 .80 .83 .80
Dnaja3
KLA  ATP  ATP+KLA
 NM_023646 DnaJ (Hsp40) homolog, subfamily A, member 3 (Dnaja3), mRNA [NM_023646] KLA .94 .98 .91 .82 .68 .74 1.22
ATP .97 1.07 .92 .88 .53 .73 .99
KLA/ATP .97 .97 .79 .86 .54 .64 .60
Egr2
KLA  ATP  ATP+KLA
 NM_010118 early growth response 2 (Egr2), mRNA [NM_010118] KLA .20 .24 .23 .28 .25 .15 .08
ATP 4.23 6.98 16.71 19.88 4.99 1.41 1.59
KLA/ATP 1.38 4.50 10.98 12.78 3.75 .37 .22
Egr3
KLA  ATP  ATP+KLA
 AK141603 adult male hippocampus cDNA, RIKEN full-length enriched library, clone:C630040P19 product:early growth response 3, full insert sequence [AK141603] KLA .81 .72 .71 .88 .85 .97 1.06
ATP 5.68 9.14 5.47 5.06 2.48 1.16 1.00
KLA/ATP 1.15 1.45 1.03 1.53 1.29 1.02 1.13
Egr3
KLA  ATP  ATP+KLA
 NM_018781 early growth response 3 (Egr3), mRNA [NM_018781] KLA 1.02 1.05 .97 1.04 1.02 1.05 .97
ATP 1.18 1.36 1.25 1.00 1.00 1.02 .94
KLA/ATP 1.02 1.02 1.09 1.02 1.03 .96 1.00
Eif2ak2
KLA  ATP  ATP+KLA
 NM_011163 eukaryotic translation initiation factor 2-alpha kinase 2 (Eif2ak2), mRNA [NM_011163] KLA 6.20 6.38 6.31 6.36 4.86 4.86 2.93
ATP 1.03 .78 .68 .37 .49 3.38 1.97
KLA/ATP 6.50 5.52 5.25 2.87 3.90 4.33 3.35
Ep300
KLA  ATP  ATP+KLA
 AK042627 7 days neonate cerebellum cDNA, RIKEN full-length enriched library, clone:A730011L11 product:P300 TRANSCRIPTION COACTIVATOR (FRAGMENT) homolog [Mus sp], full insert sequence. [AK042627] KLA 1.02 .95 .92 1.04 1.01 1.00 1.05
ATP 1.06 .89 .88 .89 1.00 .90 1.07
KLA/ATP 1.10 1.02 .87 .91 1.04 .97 .98
Ep300
KLA  ATP  ATP+KLA
 NM_177821 E1A binding protein p300 (Ep300), mRNA [NM_177821] KLA 1.61 1.26 1.57 1.38 1.78 1.41 1.40
ATP 1.34 1.60 1.11 1.08 1.16 1.05 1.15
KLA/ATP 1.86 1.94 1.18 1.56 1.71 1.42 2.05
Gcn5l2
KLA  ATP  ATP+KLA
 NM_020004 GCN5 general control of amino acid synthesis-like 2 (yeast) (Gcn5l2), transcript variant 1, mRNA [NM_020004] KLA .86 .86 .77 .82 .91 .97 1.10
ATP 1.13 1.27 1.06 1.44 .73 .63 .90
KLA/ATP 1.02 1.05 .82 1.05 .54 .62 .69
Grb2
KLA  ATP  ATP+KLA
 NM_008163 growth factor receptor bound protein 2 (Grb2), mRNA [NM_008163] KLA .92 .88 .90 1.27 1.43 1.22 1.00
ATP 1.02 .83 .51 .42 .92 .70 .57
KLA/ATP .84 .77 .61 .56 1.56 1.49 .52
Grb2
KLA  ATP  ATP+KLA
 U07617 Grb2 adaptor protein (grb2) mRNA, complete cds. [U07617] KLA .83 .80 .95 1.13 1.38 1.36 1.06
ATP .84 .74 .51 .41 .82 .74 .59
KLA/ATP .77 .70 .57 .54 1.49 1.39 .53
Gsn
KLA  ATP  ATP+KLA
 NM_146120 gelsolin (Gsn), mRNA [NM_146120] KLA .71 .69 .70 .61 .47 .39 .32
ATP .99 .86 .95 .65 .61 .44 .46
KLA/ATP .71 .80 .61 .48 .43 .32 .20
Gtf2a1
KLA  ATP  ATP+KLA
 NM_031391 general transcription factor II A, 1 (Gtf2a1), transcript variant 1, mRNA [NM_031391] KLA 1.74 2.02 2.33 2.45 2.38 2.26 1.91
ATP 1.06 1.13 1.15 2.00 2.43 2.08 2.85
KLA/ATP 1.95 2.13 1.96 2.45 2.36 2.55 3.77
Gtf2a1
KLA  ATP  ATP+KLA
 NM_175335 general transcription factor II A, 1 (Gtf2a1), transcript variant 2, mRNA [NM_175335] KLA 2.86 2.89 2.85 3.56 3.35 2.78 1.89
ATP 1.11 1.17 1.29 2.22 2.67 3.03 4.04
KLA/ATP 2.30 3.24 3.58 3.33 3.09 3.08 4.94
Gtf2a1l
KLA  ATP  ATP+KLA
 NM_023630 general transcription factor IIA, 1-like (Gtf2a1l), mRNA [NM_023630] KLA 1.02 .96 1.05 1.07 1.11 1.02 1.04
ATP .99 .97 1.08 1.01 .99 1.01 .99
KLA/ATP .99 .95 .86 .96 1.11 1.02 .98
Gtf2a2
KLA  ATP  ATP+KLA
 NM_001039519 general transcription factor II A, 2 (Gtf2a2), mRNA [NM_001039519] KLA .97 .99 .98 1.02 .86 .83 .74
ATP .99 .98 1.25 1.05 1.17 .98 .76
KLA/ATP .92 .92 1.17 .94 1.08 1.00 .77
Gtf2b
KLA  ATP  ATP+KLA
 NM_145546 general transcription factor IIB (Gtf2b), mRNA [NM_145546] KLA 2.06 1.99 1.46 1.18 .94 .88 .85
ATP 1.00 .93 1.09 1.23 2.23 2.17 1.20
KLA/ATP 1.92 1.96 2.20 1.95 2.26 2.78 1.44
Gtf2e1
KLA  ATP  ATP+KLA
 NM_028812 general transcription factor II E, polypeptide 1 (alpha subunit) (Gtf2e1), mRNA [NM_028812] KLA 1.19 1.16 .97 .85 .75 .89 .98
ATP .91 .85 .88 .53 .45 1.05 .94
KLA/ATP 1.05 1.03 .91 .63 .45 .75 .72
Gtf2e2
KLA  ATP  ATP+KLA
 NM_026584 general transcription factor II E, polypeptide 2 (beta subunit) (Gtf2e2), mRNA [NM_026584] KLA .89 .90 1.13 1.14 1.00 1.06 .99
ATP 1.02 .98 1.34 1.07 .81 1.65 1.22
KLA/ATP .88 1.01 1.43 1.08 1.01 1.33 1.03
Gtf2h1
KLA  ATP  ATP+KLA
 NM_008186 general transcription factor II H, polypeptide 1 (Gtf2h1), mRNA [NM_008186] KLA .96 .91 .87 1.10 1.18 1.19 1.30
ATP 1.04 .96 1.16 1.24 1.93 1.49 1.38
KLA/ATP .88 .84 .93 1.15 2.20 1.65 1.38
Gtf2h2
KLA  ATP  ATP+KLA
 BC016231 general transcription factor II H, polypeptide 2, mRNA (cDNA clone MGC:28787 IMAGE:4488798), complete cds. [BC016231] KLA .77 .82 .79 .88 1.07 1.44 1.58
ATP 1.03 1.00 1.15 .96 .77 .97 1.42
KLA/ATP .82 .79 .85 .82 1.12 1.95 1.99
Gtf2h2
KLA  ATP  ATP+KLA
 NM_022011 general transcription factor II H, polypeptide 2 (Gtf2h2), mRNA [NM_022011] KLA .77 .82 .76 .74 .81 1.02 1.46
ATP 1.04 1.02 1.07 1.00 .60 .76 .96
KLA/ATP .71 .75 .73 .69 .52 .88 .91
Gtf2h3
KLA  ATP  ATP+KLA
 NM_181410 general transcription factor IIH, polypeptide 3 (Gtf2h3), mRNA [NM_181410] KLA 1.02 1.09 1.11 1.16 1.31 1.44 1.51
ATP .94 .97 .97 .95 .51 .70 1.43
KLA/ATP 1.00 1.06 1.05 1.12 .76 .82 1.32
Gtf2h4
KLA  ATP  ATP+KLA
 NM_010364 general transcription factor II H, polypeptide 4 (Gtf2h4), mRNA [NM_010364] KLA .96 1.08 .98 .99 .94 .88 .98
ATP 1.00 .98 .71 .69 .50 .77 .91
KLA/ATP 1.09 1.09 .78 .80 .56 .64 .57
H2-Bl
KLA  ATP  ATP+KLA
 NM_008199 histocompatibility 2, blastocyst (H2-Bl), mRNA [NM_008199] KLA 1.29 1.32 1.40 1.28 1.36 1.46 1.80
ATP 1.04 1.11 1.02 1.34 1.28 1.32 1.47
KLA/ATP 1.32 1.39 1.34 1.77 1.41 1.61 2.39
H2-D1
KLA  ATP  ATP+KLA
 AK169750 2 days neonate thymus thymic cells cDNA, RIKEN full-length enriched library, clone:E430019E13 product:histocompatibility 2, D region locus 1, full insert sequence [AK169750] KLA .99 .98 .96 .99 .93 .91 .94
ATP .96 1.01 1.02 .95 1.05 1.00 .98
KLA/ATP .92 .94 .97 .97 .98 .92 1.03
H2-D1
KLA  ATP  ATP+KLA
 NM_010380 histocompatibility 2, D region locus 1 (H2-D1), mRNA [NM_010380] KLA 1.38 1.45 1.73 1.42 1.70 1.76 2.56
ATP 1.15 1.11 .86 1.12 1.19 1.28 1.90
KLA/ATP 1.58 1.72 1.38 1.56 1.38 1.69 3.21
H2-K1
KLA  ATP  ATP+KLA
 M69070 mRNA, complete cds. [M69070] KLA 1.76 1.66 1.78 1.78 1.87 2.23 2.99
ATP .98 .97 1.19 1.45 1.36 1.68 2.17
KLA/ATP 1.68 1.70 1.87 1.96 1.87 2.13 3.82
H2-K1
KLA  ATP  ATP+KLA
 NM_001001892 histocompatibility 2, K1, K region (H2-K1), transcript variant 1, mRNA [NM_001001892] KLA 1.82 1.66 1.73 1.76 1.87 2.29 3.17
ATP .98 .97 1.13 1.32 1.29 1.57 2.09
KLA/ATP 1.64 1.71 1.77 1.82 1.71 2.12 3.91
H2-M1
KLA  ATP  ATP+KLA
 NM_177636 histocompatibility 2, M region locus 1 (H2-M1), mRNA [NM_177636] KLA .99 1.01 1.02 1.02 .97 1.03 1.04
ATP 1.01 .99 1.03 1.07 .92 1.03 .98
KLA/ATP 1.08 .97 .94 1.04 1.00 1.04 1.02
H2-M10.1
KLA  ATP  ATP+KLA
 NM_013544 histocompatibility 2, M region locus 10.1 (H2-M10.1), mRNA [NM_013544] KLA 1.04 1.00 1.05 .95 .98 1.04 .94
ATP 1.06 1.04 .96 .95 .97 .98 .98
KLA/ATP 1.02 1.07 .98 1.02 .92 .92 .99
H2-M10.2
KLA  ATP  ATP+KLA
 NM_177923 histocompatibility 2, M region locus 10.2 (H2-M10.2), mRNA [NM_177923] KLA 2.18 2.23 2.51 2.61 2.90 3.30 3.40
ATP 1.08 1.02 1.22 1.39 1.30 1.56 2.66
KLA/ATP 2.23 2.53 2.82 2.91 2.89 2.60 3.92
H2-M10.3
KLA  ATP  ATP+KLA
 AY211080 major histocompatibility complex class Ib M10.3 mRNA, complete cds [AY211080] KLA .95 1.08 .99 .95 1.00 1.11 1.04
ATP .98 .96 1.00 .99 1.00 .99 1.00
KLA/ATP 1.00 .99 1.00 1.00 .99 .96 1.03
H2-M10.4
KLA  ATP  ATP+KLA
 NM_177634 histocompatibility 2, M region locus 10.4 (H2-M10.4), mRNA [NM_177634] KLA 1.03 1.04 1.08 1.08 1.04 1.03 1.03
ATP 1.07 1.05 .97 1.08 .95 .97 1.02
KLA/ATP 1.02 .97 1.02 .99 .93 1.06 1.04
H2-M10.5
KLA  ATP  ATP+KLA
 NM_177637 histocompatibility 2, M region locus 10.5 (H2-M10.5), mRNA [NM_177637] KLA 1.00 1.04 1.13 .93 .99 1.00 1.07
ATP 1.02 1.02 1.04 .90 1.03 .99 .99
KLA/ATP 1.06 1.03 .97 1.03 1.03 .98 1.04
H2-M10.6
KLA  ATP  ATP+KLA
 NM_201611 histocompatibility 2, M region locus 10.6 (H2-M10.6), mRNA [NM_201611] KLA 1.06 .99 1.04 1.06 .98 1.03 .92
ATP 1.04 1.09 .96 .98 .94 1.07 .98
KLA/ATP 1.01 1.06 1.02 .96 .96 1.04 1.05
H2-M11
KLA  ATP  ATP+KLA
 NM_177635 histocompatibility 2, M region locus 11 (H2-M11), mRNA [NM_177635] KLA 1.03 1.07 1.06 1.02 .96 1.05 1.03
ATP 1.02 .96 1.08 .98 1.04 .94 .98
KLA/ATP 1.03 1.03 .99 1.01 1.01 .98 .99
H2-M3
KLA  ATP  ATP+KLA
 NM_013819 histocompatibility 2, M region locus 3 (H2-M3), mRNA [NM_013819] KLA 1.90 2.04 2.09 2.37 2.30 2.56 2.73
ATP 1.00 1.00 1.19 1.34 1.00 .70 1.09
KLA/ATP 1.77 1.94 2.37 2.49 1.89 1.67 2.06
H2-M9
KLA  ATP  ATP+KLA
 NM_008205 histocompatibility 2, M region locus 9 (H2-M9), mRNA [NM_008205] KLA 1.03 .99 .96 .98 1.01 .99 1.03
ATP .96 1.06 .94 .96 1.05 1.06 1.00
KLA/ATP .96 1.01 1.01 .99 .97 .95 .98
H2-Q1
KLA  ATP  ATP+KLA
 NM_010390 histocompatibility 2, Q region locus 1 (H2-Q1), mRNA [NM_010390] KLA 1.05 1.08 1.03 1.02 .98 1.09 1.00
ATP .99 .92 .93 1.01 1.01 1.04 1.00
KLA/ATP 1.07 1.00 1.00 .91 .97 1.07 1.04
H2-Q10
KLA  ATP  ATP+KLA
 NM_010391 histocompatibility 2, Q region locus 10 (H2-Q10), mRNA [NM_010391] KLA 1.50 1.50 1.70 1.64 1.67 1.79 2.18
ATP 1.12 1.11 1.09 1.46 1.42 1.43 1.69
KLA/ATP 1.61 1.72 1.79 1.94 1.81 1.81 2.93
H2-Q2
KLA  ATP  ATP+KLA
 NM_010392 histocompatibility 2, Q region locus 2 (H2-Q2), mRNA [NM_010392] KLA 1.55 1.52 1.61 1.45 1.83 1.94 2.47
ATP 1.09 1.13 .92 1.16 1.17 1.30 1.88
KLA/ATP 1.55 1.70 1.58 1.80 1.64 1.87 3.43
H2-Q7
KLA  ATP  ATP+KLA
 NM_010394 histocompatibility 2, Q region locus 7 (H2-Q7), mRNA [NM_010394] KLA 1.57 1.58 1.74 1.55 1.82 2.00 2.76
ATP 1.05 1.09 .84 1.12 1.12 1.23 2.00
KLA/ATP 1.63 1.75 1.43 1.67 1.53 1.80 3.48
H2-Q8
KLA  ATP  ATP+KLA
 NM_023124 histocompatibility 2, Q region locus 8 (H2-Q8), mRNA [NM_023124] KLA 7.48 6.46 6.41 7.15 7.46 9.60 18.27
ATP 1.01 .98 1.48 2.05 1.93 3.83 8.26
KLA/ATP 6.72 7.10 9.11 10.95 10.71 12.88 31.43
H2-T22
KLA  ATP  ATP+KLA
 NM_010397 histocompatibility 2, T region locus 22 (H2-T22), mRNA [NM_010397] KLA 5.21 5.40 5.81 6.31 7.42 9.49 7.50
ATP 1.01 .95 .88 .92 .93 3.65 5.53
KLA/ATP 4.83 5.12 4.58 4.74 4.81 6.89 14.89
H2-T23
KLA  ATP  ATP+KLA
 NM_010398 histocompatibility 2, T region locus 23 (H2-T23), mRNA [NM_010398] KLA 1.83 1.80 1.92 1.86 2.32 2.56 3.43
ATP 1.03 1.08 .85 1.18 1.09 1.30 2.49
KLA/ATP 1.76 1.92 1.62 1.93 1.76 2.13 4.06
H2-T24
KLA  ATP  ATP+KLA
 NM_008207 histocompatibility 2, T region locus 24 (H2-T24), mRNA [NM_008207] KLA 3.02 3.26 4.14 4.26 5.15 6.06 5.89
ATP 1.08 1.09 1.32 1.35 1.17 1.71 6.71
KLA/ATP 3.23 3.31 3.54 3.85 3.07 3.73 9.10
H2-T3
KLA  ATP  ATP+KLA
 NM_008208 histocompatibility 2, T region locus 3 (H2-T3), mRNA [NM_008208] KLA .95 1.04 1.00 .97 .97 .99 1.00
ATP .98 1.08 1.03 1.01 .98 1.02 1.03
KLA/ATP 1.05 .96 1.02 1.04 1.05 1.00 .97
Hdac1
KLA  ATP  ATP+KLA
 U80780 putative histone deacetylase (HD1) mRNA, partial cds [U80780] KLA 2.59 2.39 2.48 2.74 3.36 2.56 1.22
ATP 1.13 1.26 1.18 1.08 .85 1.29 1.15
KLA/ATP 2.15 2.27 2.64 2.57 1.78 1.89 2.31
Hdac10
KLA  ATP  ATP+KLA
 NM_199198 histone deacetylase 10 (Hdac10), mRNA [NM_199198] KLA .66 .66 .66 .69 .72 .73 .76
ATP 1.05 1.05 .88 .81 .59 .48 .69
KLA/ATP .75 .72 .69 .71 .55 .54 .60
Hdac11
KLA  ATP  ATP+KLA
 NM_144919 histone deacetylase 11 (Hdac11), mRNA [NM_144919] KLA .82 .83 .86 .82 .77 .79 .78
ATP 1.02 1.07 .99 .85 .77 .75 .69
KLA/ATP .79 .81 .85 .74 .72 .78 .67
Hdac2
KLA  ATP  ATP+KLA
 AK051753 12 days embryo spinal ganglion cDNA, RIKEN full-length enriched library, clone:D130072G11 product:histone deacetylase 2, full insert sequence [AK051753] KLA .97 .97 .90 .96 1.02 .93 .96
ATP 1.02 1.03 .98 .96 .96 .90 1.05
KLA/ATP 1.00 .96 .87 .99 .92 1.00 .95
Hdac2
KLA  ATP  ATP+KLA
 NM_008229 histone deacetylase 2 (Hdac2), mRNA [NM_008229] KLA 1.27 1.35 1.33 1.18 1.03 .75 1.10
ATP .95 1.05 .79 .96 .82 .85 .81
KLA/ATP 1.28 1.43 .93 1.10 .82 .73 .60
Hdac3
KLA  ATP  ATP+KLA
 NM_010411 histone deacetylase 3 (Hdac3), mRNA [NM_010411] KLA .99 1.02 1.00 .97 1.00 1.10 .95
ATP .98 1.07 1.11 1.17 1.04 1.07 1.00
KLA/ATP 1.01 1.05 .97 1.08 1.00 1.14 1.28
Hdac4
KLA  ATP  ATP+KLA
 NM_207225 histone deacetylase 4 (Hdac4), mRNA [NM_207225] KLA .57 .59 .47 .49 .48 .54 .71
ATP 1.00 1.01 .84 1.35 1.05 1.51 .65
KLA/ATP .56 .54 .51 .69 .67 1.29 1.02
Hdac5
KLA  ATP  ATP+KLA
 NM_001077696 histone deacetylase 5 (Hdac5), transcript variant 1, mRNA [NM_001077696] KLA .41 .37 .37 .42 .52 .82 .76
ATP .95 .91 1.11 1.19 .66 .77 1.09
KLA/ATP .40 .36 .43 .50 .68 1.09 1.42
Hdac6
KLA  ATP  ATP+KLA
 NM_010413 histone deacetylase 6 (Hdac6), mRNA [NM_010413] KLA .72 .73 .65 .57 .55 .53 .63
ATP .98 1.01 .84 .90 .80 .90 .70
KLA/ATP .77 .71 .54 .64 .56 .72 .66
Hdac7
KLA  ATP  ATP+KLA
 NM_019572 histone deacetylase 7 (Hdac7), mRNA [NM_019572] KLA .64 .62 .61 .82 1.37 1.41 1.35
ATP 1.01 1.07 1.00 1.05 .74 1.00 1.40
KLA/ATP .66 .67 .68 .73 .74 .73 1.83
Hdac8
KLA  ATP  ATP+KLA
 NM_027382 histone deacetylase 8 (Hdac8), mRNA [NM_027382] KLA .93 1.03 .92 .99 .94 1.01 1.00
ATP .91 1.01 .97 .98 .77 .85 .86
KLA/ATP .94 1.02 .96 .99 .91 .85 .82
Hdac9
KLA  ATP  ATP+KLA
 NM_024124 histone deacetylase 9 (Hdac9), mRNA [NM_024124] KLA .77 .78 .74 .84 1.15 .96 .93
ATP .89 1.02 1.20 1.00 .60 .57 .69
KLA/ATP .69 .87 .88 .77 .73 .50 .81
Hist1h2b
a
KLA  ATP  ATP+KLA
 NM_175663 histone cluster 1, H2ba (Hist1h2ba), mRNA [NM_175663] KLA 1.02 .98 .79 .95 .80 1.30 2.48
ATP 1.08 .95 1.96 3.71 4.00 4.55 2.49
KLA/ATP .97 .88 1.87 2.92 3.78 3.95 3.51
Hist1h2b
c
KLA  ATP  ATP+KLA
 NM_023422 histone cluster 1, H2bc (Hist1h2bc), mRNA [NM_023422] KLA .91 .87 .80 .86 .74 1.35 2.94
ATP 1.00 .83 1.89 4.30 4.12 4.38 2.35
KLA/ATP 1.07 .82 1.29 2.92 3.55 4.37 4.26
Hist1h2b
e
KLA  ATP  ATP+KLA
 NM_178194 histone cluster 1, H2be (Hist1h2be), mRNA [NM_178194] KLA .91 1.00 1.00 1.01 .91 1.06 1.13
ATP 1.02 1.07 1.09 1.04 .99 1.02 1.00
KLA/ATP 1.06 1.01 1.06 1.09 1.04 1.03 1.06
Hist1h2b
k
KLA  ATP  ATP+KLA
 NM_175665 histone cluster 1, H2bk (Hist1h2bk), mRNA [NM_175665] KLA .88 .91 .82 .88 .75 1.25 2.49
ATP .97 .83 2.07 3.65 3.58 3.77 2.19
KLA/ATP .94 .81 1.52 2.51 3.36 3.76 3.20
Hist1h2b
m
KLA  ATP  ATP+KLA
 NM_178200 histone cluster 1, H2bm (Hist1h2bm), mRNA [NM_178200] KLA .88 .90 .80 .81 .68 1.18 2.48
ATP .94 .86 2.00 3.59 3.39 3.57 2.23
KLA/ATP .91 .80 1.42 2.43 3.16 3.54 3.19
Hist1h2b
p
KLA  ATP  ATP+KLA
 AK076671 adult male testis cDNA, RIKEN full-length enriched library, clone:4930408P03 product:HISTONE H2B (FRAGMENT) homolog [Mus musculus], full insert sequence. [AK076671] KLA .84 .87 .93 .94 .85 .92 1.04
ATP .97 .91 1.23 1.40 1.02 .80 .91
KLA/ATP .87 .82 .88 .95 .92 .87 .88
Hist1h4a
KLA  ATP  ATP+KLA
 NM_178192 histone cluster 1, H4a (Hist1h4a), mRNA [NM_178192] KLA .83 .88 .73 .73 .54 .67 .40
ATP .78 .91 2.28 2.85 1.76 1.53 .74
KLA/ATP .66 .73 1.64 1.84 1.35 1.15 .74
Hist1h4d
KLA  ATP  ATP+KLA
 NM_175654 histone cluster 1, H4d (Hist1h4d), mRNA [NM_175654] KLA .77 .78 .64 .59 .42 .53 .29
ATP .83 .90 1.97 2.16 1.33 1.09 .55
KLA/ATP .61 .63 1.19 1.24 .78 .67 .49
Hist1h4f
KLA  ATP  ATP+KLA
 NM_175655 histone cluster 1, H4f (Hist1h4f), mRNA [NM_175655] KLA .67 .71 .59 .53 .38 .48 .29
ATP .79 .86 1.99 2.30 1.46 1.29 .66
KLA/ATP .55 .56 1.07 1.17 .84 .86 .63
Hist1h4i
KLA  ATP  ATP+KLA
 BF467941 gb|UI-M-CC0-ayb-f-07-0-UI.r1 NIH_BMAP_Ret1 Mus musculus cDNA clone UI-M-CC0-ayb-f-07-0-UI 5. [BF467941] KLA 1.10 1.11 1.14 1.22 .92 1.30 1.57
ATP .67 .79 4.06 5.43 4.86 5.73 3.17
KLA/ATP .99 1.23 3.46 3.53 4.21 3.78 5.09
Hist2h2b
b
KLA  ATP  ATP+KLA
 BC019122 histone cluster 2, H2bb, mRNA (cDNA clone MGC:29103 IMAGE:5003093), complete cds [BC019122] KLA .98 1.08 1.07 1.07 1.10 1.16 1.08
ATP .89 .87 1.96 5.64 2.29 1.19 1.03
KLA/ATP 1.02 .98 1.69 5.25 2.33 1.47 1.29
Hist2h2b
e
KLA  ATP  ATP+KLA
 NM_178214 histone cluster 2, H2be (Hist2h2be), mRNA [NM_178214] KLA .94 .96 .86 .71 .69 1.19 .98
ATP .76 .68 1.00 .72 .61 .83 1.16
KLA/ATP 1.22 1.01 2.41 3.18 3.20 2.00 1.97
Hist2h4
KLA  ATP  ATP+KLA
 NM_033596 histone cluster 2, H4 (Hist2h4), mRNA [NM_033596] KLA .77 .79 .68 .60 .41 .51 .29
ATP .83 .93 2.16 2.49 1.59 1.44 .65
KLA/ATP .64 .64 1.32 1.39 1.00 .92 .63
Hist3h2b
a
KLA  ATP  ATP+KLA
 NM_030082 histone cluster 3, H2ba (Hist3h2ba), mRNA [NM_030082] KLA .84 .93 .98 .92 .87 1.37 1.55
ATP .91 .91 1.41 1.22 .93 .84 .85
KLA/ATP .80 .83 1.14 1.11 .97 2.07 7.01
Hist3h2b
b
KLA  ATP  ATP+KLA
 NM_206882 histone cluster 3, H2bb (Hist3h2bb), mRNA [NM_206882] KLA 1.01 .93 .83 .90 .79 1.25 2.56
ATP 1.10 .97 2.03 3.38 3.78 3.89 2.43
KLA/ATP 1.04 .89 1.63 2.55 3.35 3.88 3.43
Hist4h4
KLA  ATP  ATP+KLA
 AK045187 9.5 days embryo parthenogenote cDNA, RIKEN full-length enriched library, clone:B130044J01 product:H4 HISTONE homolog [Homo sapiens], full insert sequence [AK045187] KLA .96 .90 1.02 1.03 .97 1.01 1.03
ATP 1.01 1.07 .97 .99 .95 1.01 1.00
KLA/ATP 1.00 1.13 .97 1.04 1.03 1.00 .98
Hist4h4
KLA  ATP  ATP+KLA
 NM_175652 histone cluster 4, H4 (Hist4h4), mRNA [NM_175652] KLA .81 .87 .69 .76 .54 .67 .40
ATP .84 .92 2.25 2.71 1.64 1.51 .72
KLA/ATP .69 .75 1.53 1.74 1.28 1.08 .80
Hnrpk
KLA  ATP  ATP+KLA
 BC089328 heterogeneous nuclear ribonucleoprotein K, mRNA (cDNA clone MGC:102032 IMAGE:6402614), complete cds [BC089328] KLA 1.05 1.04 .97 1.01 .99 .91 .81
ATP 1.04 1.11 1.08 1.11 1.09 .86 .74
KLA/ATP 1.02 .98 .86 .95 .91 .71 .56
Hnrpk
KLA  ATP  ATP+KLA
 NM_025279 heterogeneous nuclear ribonucleoprotein K (Hnrpk), mRNA [NM_025279] KLA 1.14 1.14 1.21 1.15 1.02 1.00 .91
ATP .93 1.13 1.22 1.16 1.06 .89 .87
KLA/ATP .99 1.24 1.34 1.17 .97 .91 .71
Hpn
KLA  ATP  ATP+KLA
 NM_008281 hepsin (Hpn), transcript variant 2, mRNA [NM_008281] KLA 1.15 1.14 1.26 1.22 1.47 1.41 1.91
ATP .93 .91 .94 .96 1.09 1.51 1.00
KLA/ATP 1.11 1.16 1.13 1.10 1.39 1.09 1.23
Hras1
KLA  ATP  ATP+KLA
 NM_008284 Harvey rat sarcoma virus oncogene 1 (Hras1), mRNA [NM_008284] KLA .79 .82 .77 .82 .94 1.03 1.07
ATP 1.01 .95 .69 .83 .79 1.12 1.15
KLA/ATP .84 .77 .61 .65 .82 1.00 1.05
Ikbkg
KLA  ATP  ATP+KLA
 AK042138 3 days neonate thymus cDNA, RIKEN full-length enriched library, clone:A630062P04 product:unclassifiable, full insert sequence. [AK042138] KLA .92 .87 .78 .78 .87 .88 .62
ATP .84 .71 .80 .50 1.15 2.33 .61
KLA/ATP .72 .69 .74 .48 1.06 1.97 .68
Ikbkg
KLA  ATP  ATP+KLA
 NM_010547 inhibitor of kappaB kinase gamma (Ikbkg), transcript variant 1, mRNA [NM_010547] KLA 1.51 1.63 1.74 1.83 1.83 1.73 1.72
ATP .80 .79 .82 .75 .66 2.58 2.37
KLA/ATP 1.43 1.42 1.17 1.04 .71 1.54 3.17
Ikbkg
KLA  ATP  ATP+KLA
 NM_178590 inhibitor of kappaB kinase gamma (Ikbkg), transcript variant 2, mRNA [NM_178590] KLA .84 .93 .86 .91 1.03 .89 .88
ATP 1.03 .98 .68 .56 .51 .93 .68
KLA/ATP .89 .81 .55 .52 .41 .67 .65
Il6st
KLA  ATP  ATP+KLA
 NM_010560 interleukin 6 signal transducer (Il6st), mRNA [NM_010560] KLA .31 .30 .36 .34 .33 .35 .42
ATP 1.16 1.12 .82 .62 1.58 1.85 1.25
KLA/ATP .38 .37 .30 .27 .78 1.56 .98
Irf3
KLA  ATP  ATP+KLA
 ENSMUST00000107835 ens|Interferon regulatory factor 3 (IRF-3). [Source:Uniprot/SWISSPROT;Acc:P70671] [ENSMUST00000107835] KLA .55 .56 .60 .72 .88 .88 .98
ATP .77 .58 .50 .46 .80 .97 1.03
KLA/ATP .51 .46 .49 .53 .92 .85 .79
Irf3
KLA  ATP  ATP+KLA
 NM_016849 interferon regulatory factor 3 (Irf3), mRNA [NM_016849] KLA .79 .75 .71 .83 .88 1.07 .99
ATP .92 .84 .88 .61 .54 1.27 1.22
KLA/ATP .78 .78 .75 .58 .70 1.13 1.38
Irf7
KLA  ATP  ATP+KLA
 NM_016850 interferon regulatory factor 7 (Irf7), mRNA [NM_016850] KLA 4.90 4.72 5.85 5.82 7.67 10.64 15.44
ATP 1.14 1.10 .86 1.18 .96 2.46 12.17
KLA/ATP 5.41 5.22 4.15 6.29 5.31 9.74 29.08
Irf9
KLA  ATP  ATP+KLA
 NM_008394 interferon regulatory factor 9 (Irf9), mRNA [NM_008394] KLA 1.96 1.99 2.13 1.83 1.81 1.85 1.71
ATP 1.08 1.06 .96 1.19 1.21 2.33 2.42
KLA/ATP 2.31 2.30 1.92 2.85 2.29 3.20 4.37
Jak1
KLA  ATP  ATP+KLA
 AK029232 0 day neonate head cDNA, RIKEN full-length enriched library, clone:4831433J01 product:Janus kinase 1, full insert sequence. [AK029232] KLA 1.25 1.13 1.19 1.31 1.24 1.17 1.14
ATP 1.01 1.11 .96 1.38 1.06 1.26 1.05
KLA/ATP 1.19 1.29 1.27 1.59 1.18 1.38 1.24
Jak1
KLA  ATP  ATP+KLA
 NM_146145 Janus kinase 1 (Jak1), mRNA [NM_146145] KLA 1.71 1.75 1.79 1.81 1.72 1.37 1.21
ATP 1.03 1.01 .75 1.04 1.32 1.90 1.14
KLA/ATP 1.84 1.73 1.49 2.07 2.01 1.83 1.68
Jak3
KLA  ATP  ATP+KLA
 NM_010589 Janus kinase 3 (Jak3), mRNA [NM_010589] KLA 1.46 1.56 1.79 1.62 2.05 1.72 1.65
ATP 1.11 1.19 .84 1.25 .82 .61 .71
KLA/ATP 1.76 1.82 1.10 1.74 .93 .83 1.01
Jun
KLA  ATP  ATP+KLA
 NM_010591 Jun oncogene (Jun), mRNA [NM_010591] KLA 1.08 .96 1.09 1.09 .75 .88 .81
ATP 1.26 1.48 4.45 8.73 4.02 1.16 1.99
KLA/ATP 1.12 1.38 3.52 5.17 3.32 .49 1.42
Kras
KLA  ATP  ATP+KLA
 NM_021284 v-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog (Kras), mRNA [NM_021284] KLA .53 .49 .40 .42 .49 .95 1.05
ATP .98 1.01 1.16 1.17 1.39 1.29 1.74
KLA/ATP .50 .47 .50 .56 1.00 1.24 1.58
LOC67670
8
KLA  ATP  ATP+KLA
 XM_992322 ref|PREDICTED: Mus musculus similar to class I (Qa) Q2k antigen (LOC676708), mRNA [XM_992322] KLA 2.18 2.22 2.32 2.27 2.28 2.77 3.62
ATP 1.04 1.17 1.17 2.19 1.83 1.75 2.30
KLA/ATP 2.20 2.44 2.25 3.41 2.30 2.63 5.00
Ltbr
KLA  ATP  ATP+KLA
 NM_010736 lymphotoxin B receptor (Ltbr), mRNA [NM_010736] KLA .78 .77 .80 .95 1.08 1.39 1.36
ATP .94 .86 1.00 .83 .74 1.18 1.37
KLA/ATP .69 .71 .74 .68 .85 1.04 1.69
Lyn
KLA  ATP  ATP+KLA
 NM_010747 Yamaguchi sarcoma viral (v-yes-1) oncogene homolog (Lyn), transcript variant 2, mRNA [NM_010747] KLA 2.48 2.80 3.76 3.81 5.30 4.57 2.46
ATP 1.06 1.18 .82 .97 .74 1.45 1.21
KLA/ATP 2.82 3.16 2.24 2.87 1.73 1.80 2.63
Mad1l1
KLA  ATP  ATP+KLA
 NM_010752 mitotic arrest deficient 1-like 1 (Mad1l1), mRNA [NM_010752] KLA .92 .84 .84 .78 .59 .63 .61
ATP .94 .99 1.19 1.39 .78 .52 .72
KLA/ATP .87 .92 .91 .96 .68 .54 .59
Mapk1
KLA  ATP  ATP+KLA
 NM_001038663 mitogen-activated protein kinase 1 (Mapk1), transcript variant 2, mRNA [NM_001038663] KLA .97 1.03 .93 .86 .79 1.01 1.04
ATP .96 1.18 1.01 1.13 .84 1.04 1.16
KLA/ATP .99 .99 .84 .87 .63 .96 1.26
Mapk1
KLA  ATP  ATP+KLA
 NM_011949 mitogen-activated protein kinase 1 (Mapk1), transcript variant 1, mRNA [NM_011949] KLA .88 .80 .80 .73 .75 .76 .65
ATP .97 .96 1.06 .88 .90 .68 .48
KLA/ATP .82 .81 .78 .65 .64 .64 .45
Mapk3
KLA  ATP  ATP+KLA
 NM_011952 mitogen-activated protein kinase 3 (Mapk3), mRNA [NM_011952] KLA .81 .85 .88 .72 .79 .73 .90
ATP 1.13 1.30 .92 1.48 1.08 .68 1.03
KLA/ATP 1.01 1.01 .66 1.13 .77 .77 1.16
Mapkapk2
KLA  ATP  ATP+KLA
 NM_008551 MAP kinase-activated protein kinase 2 (Mapkapk2), mRNA [NM_008551] KLA 5.20 5.49 5.81 5.35 5.43 2.98 2.19
ATP 1.04 1.12 1.00 1.50 1.88 2.43 1.01
KLA/ATP 5.63 5.95 4.08 4.71 3.33 2.24 2.50
Mdm2
KLA  ATP  ATP+KLA
 NM_010786 transformed mouse 3T3 cell double minute 2 (Mdm2), mRNA [NM_010786] KLA 1.77 1.59 1.98 1.51 1.77 1.60 1.77
ATP 1.01 1.21 1.36 3.24 5.04 2.08 1.36
KLA/ATP 1.89 1.86 2.93 5.65 5.98 2.78 2.64
Mm.19506
1
KLA  ATP  ATP+KLA
 76253707 Unknown KLA 5.35 4.83 5.36 6.20 6.87 9.80 7.83
ATP .97 .90 .96 .77 .80 3.98 5.87
KLA/ATP 4.63 4.51 4.51 3.75 4.39 7.21 16.38
Mm.21312
8
KLA  ATP  ATP+KLA
 141801344 Unknown KLA .96 .95 .83 .77 .52 .99 1.32
ATP .80 .82 1.09 .80 .83 1.19 1.46
KLA/ATP .78 .92 .98 .62 .71 .94 1.41
Mm.22665
KLA  ATP  ATP+KLA
 118136294 Unknown KLA .27 .24 .24 .28 .40 .65 .62
ATP .91 .87 1.07 1.07 .55 .70 1.09
KLA/ATP .26 .24 .27 .33 .54 1.02 1.43
Mm.25381
9
KLA  ATP  ATP+KLA
 118130676 Unknown KLA 1.81 1.88 1.96 1.62 1.89 2.44 1.56
ATP .92 .91 1.24 1.01 1.16 2.06 1.95
KLA/ATP 1.62 1.86 1.86 1.41 1.89 2.37 1.97
Mm.27304
9
KLA  ATP  ATP+KLA
 119672895 Unknown KLA .23 .22 .22 .22 .30 .51 .16
ATP 1.08 1.05 .88 .78 .47 .09 .20
KLA/ATP .28 .22 .21 .24 .26 .22 .12
Mm.27604
2
KLA  ATP  ATP+KLA
 18702319 Unknown KLA .81 .72 .70 .70 .54 .54 .67
ATP .90 .95 1.17 1.15 1.35 1.32 1.13
KLA/ATP .70 .78 .89 .83 1.09 1.13 .97
Mm.35584
KLA  ATP  ATP+KLA
 70909358 Unknown KLA .22 .25 .28 .33 .40 .77 .46
ATP 1.05 .96 1.08 .56 1.10 .79 .74
KLA/ATP .23 .25 .32 .25 .90 1.02 .60
Mm.35895
5
KLA  ATP  ATP+KLA
 30089703 Unknown KLA .90 .90 .87 .84 .75 1.22 2.50
ATP 1.06 .91 2.11 3.91 3.77 4.01 2.40
KLA/ATP 1.03 .86 1.54 2.57 3.56 3.79 3.54
Mm.37176
6
KLA  ATP  ATP+KLA
 160420311 Unknown KLA .49 .34 .80 .82 .87 1.14 1.04
ATP .43 .30 1.42 1.53 .98 3.32 1.63
KLA/ATP .38 .20 .99 1.14 1.03 2.63 1.63
Mm.37789
8
KLA  ATP  ATP+KLA
 46049028 Unknown KLA 1.08 1.00 1.07 1.02 1.10 .95 .96
ATP .98 .98 1.01 1.01 .89 1.07 1.05
KLA/ATP .95 1.00 1.13 1.00 .97 .99 1.03
Mm.37899
0
KLA  ATP  ATP+KLA
 144227203 Unknown KLA 5.51 4.67 4.55 6.22 4.34 4.26 2.87
ATP 1.00 .76 .68 .41 .53 3.65 1.93
KLA/ATP 4.53 4.63 5.45 2.73 3.51 4.58 3.75
Mm.4364
KLA  ATP  ATP+KLA
 37591174 Unknown KLA .27 .24 .28 .30 .24 .30 .33
ATP .97 .90 .94 .52 1.37 2.32 1.14
KLA/ATP .27 .24 .29 .20 .77 1.62 .76
Mm.4387
KLA  ATP  ATP+KLA
 133892666 Unknown KLA .85 .87 .85 .89 .77 .91 1.18
ATP 1.01 1.01 .87 1.07 .75 .86 .93
KLA/ATP .88 .86 .77 .81 .72 .91 .84
Mm.43967
5
KLA  ATP  ATP+KLA
 133778954 Unknown KLA 1.76 1.74 1.70 1.72 1.75 2.14 3.19
ATP 1.00 1.01 1.18 1.28 1.25 1.48 1.84
KLA/ATP 1.67 1.64 1.70 1.79 1.63 2.04 3.36
Mm.43967
5
KLA  ATP  ATP+KLA
 149275074 Unknown KLA 2.17 2.23 2.26 2.58 2.26 2.10 1.43
ATP .96 .91 1.12 .90 .70 1.10 1.47
KLA/ATP 1.96 2.10 1.92 1.51 1.12 1.35 1.99
Mm.44165
1
KLA  ATP  ATP+KLA
 160333403 Unknown KLA 5.45 5.27 5.02 6.34 6.63 10.05 8.10
ATP .91 .84 .96 .75 .78 3.91 6.03
KLA/ATP 4.29 4.38 4.50 3.55 4.22 7.22 17.63
Mm.44230
7
KLA  ATP  ATP+KLA
 30061354 Unknown KLA .68 .77 .60 .53 .36 .48 .29
ATP .76 .92 2.12 2.50 1.62 1.40 .68
KLA/ATP .59 .60 1.18 1.38 .95 .89 .66
Mm.45044
KLA  ATP  ATP+KLA
 133892959 Unknown KLA .51 .47 .52 .83 1.25 1.16 .60
ATP 1.09 .78 .80 .63 .83 .89 .41
KLA/ATP .49 .42 .44 .39 .89 1.04 .41
Mm.45107
1
KLA  ATP  ATP+KLA
 68226432 Unknown KLA .96 1.04 .99 1.06 .87 1.37 2.42
ATP .96 .86 2.23 3.91 3.43 3.57 2.09
KLA/ATP 1.01 .96 1.81 2.89 3.45 3.52 2.98
Mm.46781
1
KLA  ATP  ATP+KLA
 153792000 Unknown KLA 1.43 1.25 1.10 1.33 1.29 1.01 .59
ATP 1.08 1.15 1.09 1.08 1.12 .86 .50
KLA/ATP 1.12 1.24 1.55 1.47 1.50 1.15 .40
Mm.47124
2
KLA  ATP  ATP+KLA
 31542487 Unknown KLA .72 .67 .68 .65 .63 .80 1.06
ATP .89 .87 .96 .83 .82 .68 .95
KLA/ATP .62 .60 .60 .52 .67 .64 .58
Mm.47351
0
KLA  ATP  ATP+KLA
 162287332 Unknown KLA 4.46 4.82 5.29 4.00 2.26 1.25 1.10
ATP 1.24 1.72 1.02 2.08 1.66 2.53 .55
KLA/ATP 6.11 7.67 4.29 6.99 3.11 2.86 2.30
Mrps18b
KLA  ATP  ATP+KLA
 AK034502 adult male diencephalon cDNA, RIKEN full-length enriched library, clone:9330209A01 product:unclassifiable, full insert sequence [AK034502] KLA .88 .88 .84 .88 .89 .96 1.06
ATP .95 .86 .87 .78 .82 .92 .91
KLA/ATP .84 .77 .79 .77 .77 .80 .89
Mrps18b
KLA  ATP  ATP+KLA
 NM_025878 mitochondrial ribosomal protein S18B (Mrps18b), nuclear gene encoding mitochondrial protein, mRNA [NM_025878] KLA .84 .85 .75 .77 .85 .83 1.70
ATP 1.01 .97 .76 .75 .76 .97 .99
KLA/ATP .96 .94 .70 .62 .52 .58 .75
Nfkb1
KLA  ATP  ATP+KLA
 BC050841 nuclear factor of kappa light chain gene enhancer in B-cells 1, p105, mRNA (cDNA clone IMAGE:6392793), complete cds. [BC050841] KLA 5.81 4.96 4.77 3.21 3.37 2.00 1.71
ATP 1.39 1.52 3.25 12.63 13.64 4.80 1.08
KLA/ATP 7.21 8.69 19.53 23.93 11.70 2.85 2.01
Nfkb1
KLA  ATP  ATP+KLA
 M57999 gb|Mouse transcription factor NF-kappa-B DNA binding subunit mRNA, complete cds. [M57999] KLA 8.55 7.87 7.35 6.13 3.51 1.85 1.38
ATP .98 .96 1.21 3.06 5.29 4.67 .69
KLA/ATP 7.32 7.20 8.71 10.82 5.55 2.77 1.54
Nfkb2
KLA  ATP  ATP+KLA
 NM_019408 nuclear factor of kappa light polypeptide gene enhancer in B-cells 2, p49/p100 (Nfkb2), mRNA [NM_019408] KLA 7.31 7.92 7.95 6.42 6.41 4.42 2.81
ATP .99 .98 .72 1.48 2.80 5.31 1.44
KLA/ATP 8.25 7.93 6.51 7.68 5.08 4.38 4.86
Nfkbia
KLA  ATP  ATP+KLA
 NM_010907 nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha (Nfkbia), mRNA [NM_010907] KLA 18.65 18.46 13.63 17.88 14.25 9.17 7.92
ATP .91 1.09 7.11 32.39 17.44 10.49 1.72
KLA/ATP 15.57 17.66 15.73 23.91 13.83 10.73 9.48
Nras
KLA  ATP  ATP+KLA
 NM_010937 neuroblastoma ras oncogene (Nras), mRNA [NM_010937] KLA 1.20 1.22 1.27 1.20 1.09 .91 .84
ATP .98 .91 .69 .61 .59 .67 .78
KLA/ATP 1.22 1.14 .97 .79 .73 .61 .72
Pcaf
KLA  ATP  ATP+KLA
 NM_020005 p300/CBP-associated factor (Pcaf), mRNA [NM_020005] KLA 2.47 2.38 3.01 3.89 3.93 2.64 1.24
ATP 1.14 1.21 1.23 .99 .93 1.29 .91
KLA/ATP 2.58 2.82 3.67 2.48 2.42 2.28 2.26
Pik3ca
KLA  ATP  ATP+KLA
 ENSMUST00000108243 ens|Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha isoform (EC 2.7.1.153) (PI3-kinase p110 subunit alpha) (PtdIns-3- kinase p110) (PI3K). [Source:Uniprot/SWISSPROT;Acc:P42337] [ENSMUST00000108243] KLA 1.07 1.01 .91 .90 .98 .96 .86
ATP 1.03 .87 1.12 .63 1.22 1.86 .60
KLA/ATP 1.05 .82 .91 .61 1.17 1.26 .63
Pik3ca
KLA  ATP  ATP+KLA
 NM_008839 phosphatidylinositol 3-kinase, catalytic, alpha polypeptide (Pik3ca), mRNA [NM_008839] KLA 1.15 1.11 1.05 .82 .99 1.03 1.27
ATP .98 1.00 .79 .75 .96 1.32 1.10
KLA/ATP 1.10 .98 .64 .72 .80 1.20 1.41
Pik3cb
KLA  ATP  ATP+KLA
 NM_029094 phosphatidylinositol 3-kinase, catalytic, beta polypeptide (Pik3cb), mRNA [NM_029094] KLA 1.06 1.06 1.03 .73 .68 .98 1.69
ATP 1.04 1.21 .95 1.02 .85 .93 1.73
KLA/ATP 1.15 1.27 .73 .83 .58 .81 1.81
Pik3cd
KLA  ATP  ATP+KLA
 NM_008840 phosphatidylinositol 3-kinase catalytic delta polypeptide (Pik3cd), transcript variant 1, mRNA [NM_008840] KLA 2.28 2.42 3.10 4.17 3.35 2.31 1.34
ATP 1.02 .91 .99 .63 .30 .67 .80
KLA/ATP 2.14 2.23 2.70 1.51 1.17 .85 .72
Pik3cd
KLA  ATP  ATP+KLA
 U86587 phosphatidylinositol 3-kinase catalytic subunit p110 delta mRNA, complete cds. [U86587] KLA 2.21 2.24 3.71 3.17 3.67 2.66 1.48
ATP 1.00 1.03 .93 .96 .46 .75 .97
KLA/ATP 2.27 2.32 1.97 2.02 1.01 .99 .98
Pik3cg
KLA  ATP  ATP+KLA
 NM_020272 phosphoinositide-3-kinase, catalytic, gamma polypeptide (Pik3cg), mRNA [NM_020272] KLA .53 .53 .61 .64 .97 .86 .79
ATP 1.01 1.13 .88 .89 .52 .53 .53
KLA/ATP .58 .53 .43 .60 .40 .43 .62
Pik3r1
KLA  ATP  ATP+KLA
 NM_001077495 phosphatidylinositol 3-kinase, regulatory subunit, polypeptide 1 (p85 alpha) (Pik3r1), transcript variant 2, mRNA [NM_001077495] KLA 1.05 1.07 1.03 1.00 1.01 1.20 .85
ATP .97 1.02 1.48 1.42 1.76 1.33 1.23
KLA/ATP 1.11 1.12 1.06 1.17 1.24 .99 1.12
Pik3r2
KLA  ATP  ATP+KLA
 NM_008841 phosphatidylinositol 3-kinase, regulatory subunit, polypeptide 2 (p85 beta) (Pik3r2), mRNA [NM_008841] KLA .50 .50 .48 .43 .46 .66 .75
ATP .78 .68 .45 .43 .28 .57 1.37
KLA/ATP .49 .38 .32 .33 .38 .67 1.10
Pik3r3
KLA  ATP  ATP+KLA
 NM_181585 phosphatidylinositol 3 kinase, regulatory subunit, polypeptide 3 (p55) (Pik3r3), mRNA [NM_181585] KLA 1.59 1.49 1.37 1.17 1.05 1.55 1.41
ATP 1.12 1.00 1.33 1.70 2.01 2.37 2.02
KLA/ATP 1.63 1.54 1.58 1.70 2.43 2.68 1.92
Pik3r5
KLA  ATP  ATP+KLA
 NM_177320 phosphoinositide-3-kinase, regulatory subunit 5, p101 (Pik3r5), mRNA [NM_177320] KLA 3.57 3.58 4.16 3.54 4.11 2.59 2.39
ATP 1.08 1.08 .93 1.67 3.11 1.88 1.34
KLA/ATP 3.91 3.70 3.30 3.80 2.70 2.04 3.00
Pkm2
KLA  ATP  ATP+KLA
 D38379 mRNA for pyruvate kinase M, complete cds. [D38379] KLA .80 .83 .94 .67 .95 .95 1.42
ATP 1.22 1.30 .83 1.14 .99 1.23 2.53
KLA/ATP .99 1.03 .61 .83 .70 1.16 2.54
Pkm2
KLA  ATP  ATP+KLA
 NM_011099 pyruvate kinase, muscle (Pkm2), mRNA [NM_011099] KLA .84 .89 .95 .72 .92 1.03 1.34
ATP 1.05 1.23 .83 1.13 .96 1.20 2.14
KLA/ATP .98 .97 .64 .89 .73 1.20 2.32
Pmaip1
KLA  ATP  ATP+KLA
 NM_021451 phorbol-12-myristate-13-acetate-induced protein 1 (Pmaip1), mRNA [NM_021451] KLA .91 .86 1.19 .95 1.00 1.69 .90
ATP .83 .83 1.73 2.05 3.55 5.44 1.25
KLA/ATP .80 1.02 2.98 3.40 4.54 6.15 4.73
Polb
KLA  ATP  ATP+KLA
 BC006681 polymerase (DNA directed), beta, mRNA (cDNA clone IMAGE:3581916), complete cds [BC006681] KLA 1.62 1.31 1.52 1.37 1.57 1.35 1.17
ATP 1.04 1.03 .82 .63 .73 1.00 1.07
KLA/ATP 1.63 1.37 1.02 .72 .89 1.20 1.19
Polb
KLA  ATP  ATP+KLA
 NM_011130 polymerase (DNA directed), beta (Polb), mRNA [NM_011130] KLA 1.81 1.86 2.02 2.10 2.36 2.05 1.64
ATP .99 .99 1.19 1.34 1.16 1.04 1.62
KLA/ATP 1.80 1.83 2.05 2.17 2.03 1.73 2.49
Prkaca
KLA  ATP  ATP+KLA
 NM_008854 protein kinase, cAMP dependent, catalytic, alpha (Prkaca), mRNA [NM_008854] KLA .71 .74 .72 .70 .72 .84 .85
ATP 1.05 .98 .89 .92 .76 .60 1.02
KLA/ATP .79 .74 .55 .65 .60 .65 .93
Prkacb
KLA  ATP  ATP+KLA
 NM_011100 protein kinase, cAMP dependent, catalytic, beta (Prkacb), mRNA [NM_011100] KLA .69 .70 .66 .58 .51 .55 .59
ATP 1.02 1.19 .97 1.01 .69 .38 .56
KLA/ATP .72 .73 .57 .62 .47 .41 .45
Prkx
KLA  ATP  ATP+KLA
 NM_016979 protein kinase, X-linked (Prkx), mRNA [NM_016979] KLA 3.61 3.79 4.67 4.66 4.85 4.19 1.43
ATP .98 .90 .63 .61 1.12 1.90 1.29
KLA/ATP 3.56 3.36 2.62 2.06 2.26 2.87 2.31
Psmc1
KLA  ATP  ATP+KLA
 NM_008947 protease (prosome, macropain) 26S subunit, ATPase 1 (Psmc1), mRNA [NM_008947] KLA .77 .81 .78 .77 .96 1.40 1.65
ATP .98 1.02 .93 .98 1.01 1.61 1.77
KLA/ATP .83 .78 .71 .72 .83 1.58 2.21
Pxn
KLA  ATP  ATP+KLA
 AK084243 12 days embryo eyeball cDNA, RIKEN full-length enriched library, clone:D230012N01 product:inferred: paxillin beta {Homo sapiens}, full insert sequence. [AK084243] KLA 1.06 .92 1.01 .95 .97 .97 1.02
ATP 1.02 1.02 .97 .90 .98 .94 .89
KLA/ATP .96 .97 .98 .91 1.01 1.00 .94
Pxn
KLA  ATP  ATP+KLA
 NM_133915 paxillin (Pxn), transcript variant beta, mRNA [NM_133915] KLA 1.13 1.13 1.14 1.14 1.49 1.60 1.30
ATP 1.11 1.22 .86 1.04 1.14 1.18 1.35
KLA/ATP 1.41 1.22 .80 .92 1.07 1.54 2.60
RP23-38E
20.1
KLA  ATP  ATP+KLA
 NM_001097979 H2b histone family, member A (LOC665596), mRNA [NM_001097979] KLA .72 .54 .87 .92 .94 1.01 1.10
ATP .67 .52 1.08 1.27 .94 1.78 1.24
KLA/ATP .69 .38 .87 1.15 .98 1.46 1.21
Rac1
KLA  ATP  ATP+KLA
 NM_009007 RAS-related C3 botulinum substrate 1 (Rac1), mRNA [NM_009007] KLA 1.02 1.01 1.02 .99 1.03 1.15 1.08
ATP .99 1.15 1.01 1.27 1.06 1.20 1.06
KLA/ATP 1.00 1.04 .88 1.16 .91 1.21 1.38
Ranbp1
KLA  ATP  ATP+KLA
 X56045 gb|Mouse mRNA (clone lambda-19) for hypothetical protein A. [X56045] KLA 1.28 1.17 1.28 1.33 1.15 .99 .60
ATP 1.10 1.02 1.31 1.26 1.18 .76 .40
KLA/ATP 1.19 1.29 1.72 1.62 1.87 1.33 .30
Rasa2
KLA  ATP  ATP+KLA
 AK081420 16 days embryo head cDNA, RIKEN full-length enriched library, clone:C130016C09 product:unclassifiable, full insert sequence. [AK081420] KLA 1.12 1.06 1.09 1.04 .92 .91 1.19
ATP 1.34 1.69 2.20 1.41 1.41 .97 .97
KLA/ATP 1.10 1.18 1.48 1.09 1.02 .91 .86
Rasa2
KLA  ATP  ATP+KLA
 NM_053268 RAS p21 protein activator 2 (Rasa2), mRNA [NM_053268] KLA 1.28 1.22 .92 .86 .96 .93 1.50
ATP 1.10 1.23 .93 .92 3.23 1.69 1.61
KLA/ATP 1.40 1.43 .87 .95 1.61 1.12 1.50
Rb1
KLA  ATP  ATP+KLA
 NM_009029 retinoblastoma 1 (Rb1), mRNA [NM_009029] KLA .67 .60 .55 .51 .46 .75 .79
ATP 1.04 1.01 1.12 .86 .59 .43 .76
KLA/ATP .64 .59 .58 .46 .36 .30 .65
Rbl1
KLA  ATP  ATP+KLA
 NM_011249 retinoblastoma-like 1 (p107) (Rbl1), mRNA [NM_011249] KLA 3.37 3.24 4.88 3.79 2.52 1.65 .61
ATP 1.08 1.11 1.29 .91 .48 .56 .53
KLA/ATP 3.36 3.65 4.38 3.36 2.12 1.71 1.31
Rbl2
KLA  ATP  ATP+KLA
 NM_011250 retinoblastoma-like 2 (Rbl2), mRNA [NM_011250] KLA .66 .69 .65 .51 .55 .57 .78
ATP 1.11 1.32 .95 1.14 .57 .47 .65
KLA/ATP .77 .76 .52 .64 .41 .52 .59
Rbpj
KLA  ATP  ATP+KLA
 NM_009035 recombination signal binding protein for immunoglobulin kappa J region (Rbpj), transcript variant 1, mRNA [NM_009035] KLA .92 .88 1.03 1.33 1.65 1.48 .97
ATP 1.07 1.10 1.09 1.18 1.35 1.61 1.23
KLA/ATP .86 .86 .82 1.03 .70 .77 1.46
Rbpjl
KLA  ATP  ATP+KLA
 NM_009036 recombination signal binding protein for immunoglobulin kappa J region-like (Rbpjl), mRNA [NM_009036] KLA .94 .98 .94 .99 1.07 1.02 1.02
ATP .97 .96 1.10 1.27 1.05 1.10 .98
KLA/ATP 1.00 1.02 1.00 .95 .96 .94 1.01
Rel
KLA  ATP  ATP+KLA
 NM_009044 reticuloendotheliosis oncogene (Rel), mRNA [NM_009044] KLA 6.20 5.99 6.38 3.19 1.97 1.61 1.46
ATP 1.09 1.31 2.22 2.64 3.14 2.16 1.56
KLA/ATP 6.79 7.15 6.97 5.37 3.14 2.05 2.16
Rela
KLA  ATP  ATP+KLA
 NM_009045 v-rel reticuloendotheliosis viral oncogene homolog A (avian) (Rela), mRNA [NM_009045] KLA 2.05 2.05 2.07 1.75 1.83 1.58 1.33
ATP 1.03 1.08 1.10 1.44 1.61 2.48 1.05
KLA/ATP 2.17 2.27 2.05 2.47 1.93 2.35 2.02
Rhoa
KLA  ATP  ATP+KLA
 NM_016802 ras homolog gene family, member A (Rhoa), mRNA [NM_016802] KLA .93 1.00 1.07 .97 1.08 1.06 1.02
ATP .93 .88 .49 .61 .63 .78 1.05
KLA/ATP .94 .92 .59 .63 .61 .78 1.12
Scin
KLA  ATP  ATP+KLA
 NM_009132 scinderin (Scin), mRNA [NM_009132] KLA 1.23 1.20 1.11 .94 .94 .89 1.22
ATP .99 .96 1.22 1.23 1.62 1.21 1.65
KLA/ATP 1.08 1.26 1.18 1.35 2.00 1.38 1.58
Scrib
KLA  ATP  ATP+KLA
 NM_134089 scribbled homolog (Drosophila) (Scrib), mRNA [NM_134089] KLA .59 .49 .43 .57 .50 .51 .58
ATP 1.08 .88 .86 .80 .83 .97 .71
KLA/ATP .51 .44 .49 .46 .58 .76 .67
Skp2
KLA  ATP  ATP+KLA
 AF083215 SCF complex protein Skp2 mRNA, complete cds. [AF083215] KLA .36 .37 .34 .37 .44 .78 .60
ATP 1.05 1.35 .85 .66 .83 .54 .76
KLA/ATP .33 .39 .37 .37 .65 .73 .62
Snd1
KLA  ATP  ATP+KLA
 NM_019776 staphylococcal nuclease and tudor domain containing 1 (Snd1), mRNA [NM_019776] KLA 1.58 1.66 1.88 1.68 1.84 1.62 1.19
ATP 1.11 1.16 .69 .91 .64 .70 .93
KLA/ATP 1.86 1.76 1.28 1.41 .78 1.05 .98
Snw1
KLA  ATP  ATP+KLA
 NM_025507 SNW domain containing 1 (Snw1), mRNA [NM_025507] KLA 2.06 2.04 2.00 2.32 1.97 1.86 1.63
ATP 1.12 1.08 1.10 1.02 1.17 1.61 1.60
KLA/ATP 1.90 2.12 2.63 2.35 2.27 2.75 2.79
Sp100
KLA  ATP  ATP+KLA
 BC028649 nuclear antigen Sp100, mRNA (cDNA clone IMAGE:964034). [BC028649] KLA 3.56 3.84 4.77 4.32 5.60 4.45 3.27
ATP 1.18 1.20 .87 1.22 .83 1.79 2.98
KLA/ATP 4.53 4.50 3.04 6.18 4.20 5.02 6.16
Sp100
KLA  ATP  ATP+KLA
 NM_013673 nuclear antigen Sp100 (Sp100), mRNA [NM_013673] KLA 2.97 3.03 3.21 3.06 3.44 3.09 2.62
ATP .96 .92 .95 1.02 .80 1.43 2.39
KLA/ATP 2.91 2.81 2.80 3.29 2.43 2.32 3.82
Src
KLA  ATP  ATP+KLA
 NM_009271 Rous sarcoma oncogene (Src), transcript variant 1, mRNA [NM_009271] KLA 6.99 7.23 7.54 5.99 5.34 3.39 3.00
ATP 1.02 1.06 1.06 2.08 4.41 5.03 3.97
KLA/ATP 7.44 7.51 5.48 6.24 4.86 5.86 7.90
Srf
KLA  ATP  ATP+KLA
 NM_020493 serum response factor (Srf), mRNA [NM_020493] KLA .56 .53 .61 .82 1.37 1.04 .70
ATP 1.13 .88 .71 .68 .86 .85 .50
KLA/ATP .61 .51 .46 .42 .82 .99 .47
Stat3
KLA  ATP  ATP+KLA
 NM_213659 signal transducer and activator of transcription 3 (Stat3), transcript variant 1, mRNA [NM_213659] KLA 4.36 4.42 4.67 6.02 4.95 3.45 1.46
ATP 1.01 .97 1.07 1.17 2.47 4.04 1.47
KLA/ATP 4.02 4.57 6.65 6.51 7.06 7.39 3.61
Stat5a
KLA  ATP  ATP+KLA
 NM_011488 signal transducer and activator of transcription 5A (Stat5a), mRNA [NM_011488] KLA 8.23 8.24 6.89 4.88 4.35 1.98 1.01
ATP 1.07 1.14 1.07 1.26 3.23 3.14 1.52
KLA/ATP 8.70 9.53 7.33 6.68 4.32 2.73 1.72
Stat5b
KLA  ATP  ATP+KLA
 AK137889 16 days neonate thymus cDNA, RIKEN full-length enriched library, clone:A130035C01 product:unclassifiable, full insert sequence. [AK137889] KLA 1.10 1.01 .98 .90 1.03 .93 .88
ATP .90 .87 .61 .69 1.01 .97 .89
KLA/ATP 1.12 1.00 .87 .85 .95 1.07 .83
Stat5b
KLA  ATP  ATP+KLA
 NM_011489 signal transducer and activator of transcription 5B (Stat5b), transcript variant 1, mRNA [NM_011489] KLA 2.91 2.81 3.42 2.69 2.23 1.95 1.32
ATP .99 1.04 1.16 .97 1.00 1.84 2.09
KLA/ATP 2.96 3.05 3.17 2.99 1.86 1.87 3.40
Syk
KLA  ATP  ATP+KLA
 NM_011518 spleen tyrosine kinase (Syk), mRNA [NM_011518] KLA 2.48 2.59 2.57 2.26 3.29 3.75 3.19
ATP .96 .85 .59 1.01 2.80 3.77 2.11
KLA/ATP 2.56 2.09 1.16 1.35 2.50 4.33 5.10
Tbp
KLA  ATP  ATP+KLA
 NM_013684 TATA box binding protein (Tbp), mRNA [NM_013684] KLA 1.27 1.33 1.42 1.17 1.23 1.20 1.22
ATP 1.07 1.21 1.01 .85 .93 1.04 1.14
KLA/ATP 1.38 1.40 1.13 1.11 .93 1.13 1.12
Tbpl1
KLA  ATP  ATP+KLA
 AK028621 10 days neonate skin cDNA, RIKEN full-length enriched library, clone:4732418P20 product:TATA box binding protein-like protein, full insert sequence [AK028621] KLA 1.03 1.11 .99 .98 .97 .88 .92
ATP .95 1.03 1.05 .94 .94 .96 1.09
KLA/ATP .98 .95 .99 .98 .98 1.03 1.01
Tbpl1
KLA  ATP  ATP+KLA
 NM_011603 TATA box binding protein-like 1 (Tbpl1), mRNA [NM_011603] KLA .68 .72 .72 .71 .76 .87 1.05
ATP .93 .97 .98 .89 1.05 .97 .85
KLA/ATP .67 .66 .74 .70 1.04 1.20 1.00
Tbpl2
KLA  ATP  ATP+KLA
 NM_199059 TATA box binding protein like 2 (Tbpl2), mRNA [NM_199059] KLA 1.01 1.10 .97 1.00 .92 .96 1.04
ATP 1.01 1.03 1.04 1.02 .95 1.00 1.02
KLA/ATP 1.04 .92 .83 1.06 1.03 1.02 .97
Tradd
KLA  ATP  ATP+KLA
 NM_001033161 TNFRSF1A-associated via death domain (Tradd), mRNA [NM_001033161] KLA .77 .71 .82 .89 .89 1.11 1.06
ATP 1.00 .90 1.01 .73 .59 1.34 1.50
KLA/ATP .79 .73 .83 .63 .72 1.11 1.73
Traf1
KLA  ATP  ATP+KLA
 NM_009421 Tnf receptor-associated factor 1 (Traf1), mRNA [NM_009421] KLA 44.86 39.03 38.11 34.21 36.49 19.69 14.75
ATP 1.14 1.04 1.98 8.16 16.79 30.81 6.36
KLA/ATP 46.20 45.67 45.63 38.00 27.26 31.47 63.83
Traf2
KLA  ATP  ATP+KLA
 NM_009422 Tnf receptor-associated factor 2 (Traf2), mRNA [NM_009422] KLA 3.38 3.62 3.49 3.36 3.49 3.39 2.68
ATP .97 1.04 1.00 1.10 1.54 2.40 1.55
KLA/ATP 3.38 3.16 2.93 2.74 2.67 3.11 4.70
Traf3
KLA  ATP  ATP+KLA
 NM_011632 Tnf receptor-associated factor 3 (Traf3), transcript variant 1, mRNA [NM_011632] KLA .52 .49 .51 .49 .80 .98 1.22
ATP .93 .92 .95 1.13 2.70 1.80 1.42
KLA/ATP .56 .50 .49 1.07 2.94 1.92 1.65
Traf5
KLA  ATP  ATP+KLA
 NM_011633 Tnf receptor-associated factor 5 (Traf5), mRNA [NM_011633] KLA 1.82 1.92 1.93 2.10 2.75 2.08 1.00
ATP 1.02 1.04 1.10 .78 3.79 2.22 1.42
KLA/ATP 1.70 1.89 1.85 1.64 5.40 2.10 1.83
Trp53
KLA  ATP  ATP+KLA
 NM_011640 transformation related protein 53 (Trp53), mRNA [NM_011640] KLA 1.25 1.37 1.11 .86 .72 .71 .95
ATP 1.15 1.32 .90 1.85 1.26 .68 .70
KLA/ATP 1.66 1.49 .80 1.76 .81 .65 .74
Ube3a
KLA  ATP  ATP+KLA
 NM_011668 ubiquitin protein ligase E3A (Ube3a), transcript variant 2, mRNA [NM_011668] KLA 1.28 1.18 1.12 1.18 1.07 1.04 1.08
ATP .83 .60 .51 .30 .70 1.18 1.04
KLA/ATP 1.05 .82 .75 .42 .88 1.07 .93
Ube3a
KLA  ATP  ATP+KLA
 NM_173010 ubiquitin protein ligase E3A (Ube3a), transcript variant 1, mRNA [NM_173010] KLA 1.06 1.02 .95 .94 .96 .91 1.07
ATP .85 .63 .39 .27 .64 .83 .93
KLA/ATP .96 .72 .47 .32 .66 .78 .84
Usp7
KLA  ATP  ATP+KLA
 BC022588 ubiquitin specific peptidase 7, mRNA (cDNA clone IMAGE:4036999), **** WARNING: chimeric clone ****. [BC022588] KLA 1.29 1.16 1.15 1.01 1.20 1.07 1.01
ATP 1.22 1.35 1.25 1.13 1.42 1.03 .90
KLA/ATP 1.83 1.81 1.43 1.18 1.31 1.00 .89
Usp7
KLA  ATP  ATP+KLA
 NM_001003918 ubiquitin specific peptidase 7 (Usp7), mRNA [NM_001003918] KLA 1.49 1.46 1.42 1.41 1.07 .91 .91
ATP 1.01 .91 .90 .68 1.07 1.37 .87
KLA/ATP 1.45 1.50 1.44 .92 1.13 1.07 .73
Vac14
KLA  ATP  ATP+KLA
 AK011396 10 days embryo whole body cDNA, RIKEN full-length enriched library, clone:2610014M01 product:unclassifiable, full insert sequence. [AK011396] KLA .83 .81 .80 .90 1.01 .87 1.17
ATP 1.24 1.12 1.03 .92 1.45 .95 1.23
KLA/ATP .88 .99 .96 .79 1.28 .93 1.07
Vac14
KLA  ATP  ATP+KLA
 NM_146216 Vac14 homolog (S. cerevisiae) (Vac14), mRNA [NM_146216] KLA .80 .86 .91 .78 .82 .96 1.26
ATP .97 1.07 .81 1.07 .88 .72 1.10
KLA/ATP .89 .80 .59 .77 .64 .78 .87
Vdac3
KLA  ATP  ATP+KLA
 NM_011696 voltage-dependent anion channel 3 (Vdac3), mRNA [NM_011696] KLA 1.09 1.11 1.13 1.15 1.12 1.21 1.45
ATP .95 .96 1.06 .91 .91 1.36 1.11
KLA/ATP 1.06 1.06 1.20 1.03 1.11 1.07 1.12
Ywhab
KLA  ATP  ATP+KLA
 NM_018753 tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, beta polypeptide (Ywhab), mRNA [NM_018753] KLA 1.03 1.15 1.18 1.10 1.20 1.20 1.23
ATP 1.02 1.08 .84 1.06 1.08 1.24 1.24
KLA/ATP 1.15 1.18 .82 1.17 .91 1.24 1.58
Ywhae
KLA  ATP  ATP+KLA
 NM_009536 tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, epsilon polypeptide (Ywhae), mRNA [NM_009536] KLA 1.32 1.35 1.43 1.40 1.46 1.45 1.19
ATP 1.09 1.30 1.21 1.51 1.16 .97 1.01
KLA/ATP 1.45 1.50 1.33 1.85 1.25 1.16 1.08
Ywhag
KLA  ATP  ATP+KLA
 NM_018871 tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, gamma polypeptide (Ywhag), mRNA [NM_018871] KLA .87 .96 .92 .89 1.14 1.30 1.77
ATP 1.08 1.22 .86 .83 .91 1.46 1.09
KLA/ATP 1.05 1.04 .61 .72 .76 1.44 1.52
Ywhah
KLA  ATP  ATP+KLA
 NM_011738 tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta polypeptide (Ywhah), mRNA [NM_011738] KLA .55 .54 .49 .44 .38 .58 .70
ATP .99 .93 1.14 .81 .62 .53 1.07
KLA/ATP .54 .52 .54 .35 .37 .35 .68
Ywhaq
KLA  ATP  ATP+KLA
 AK037746 16 days neonate thymus cDNA, RIKEN full-length enriched library, clone:A130046D12 product:unclassifiable, full insert sequence [AK037746] KLA .97 .93 .94 .95 .97 .96 .95
ATP 1.09 1.07 1.44 1.49 1.04 1.01 .96
KLA/ATP 1.04 .96 1.11 1.36 1.01 1.03 .87
Ywhaq
KLA  ATP  ATP+KLA
 NM_011739 tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, theta polypeptide (Ywhaq), mRNA [NM_011739] KLA .93 .98 .96 .99 .92 .76 .88
ATP 1.07 1.08 1.01 1.35 1.37 1.28 .70
KLA/ATP .97 1.04 .94 1.17 1.09 1.18 .77
Ywhaz
KLA  ATP  ATP+KLA
 AK050511 adult pancreas islet cells cDNA, RIKEN full-length enriched library, clone:C820005J08 product:tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide, full insert sequence. [AK050511] KLA .99 .96 .97 .96 1.00 .95 .96
ATP .99 1.00 .98 1.01 1.04 .94 1.01
KLA/ATP .99 .97 1.00 .98 .88 .97 1.01
Ywhaz
KLA  ATP  ATP+KLA
 NM_011740 tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide (Ywhaz), mRNA [NM_011740] KLA 1.79 1.86 1.98 2.10 2.11 2.10 1.30
ATP 1.00 1.21 .95 1.37 1.21 1.42 1.08
KLA/ATP 1.73 1.92 1.58 2.28 1.68 1.76 1.47